As filed with the Securities and Exchange Commission on ~~September 7,~~October 9, 2018

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

(Name, address, including zip code, and telephone number, including area code, of agent for service)

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box: [X]

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Pursuant to Rule 429(a) under the Securities Act, the prospectus (“Prospectus”) included in this Registration Statement on Form S-1 (this “Registration Statement”) is a combined prospectus and also relates to an aggregate of 13,056,161 shares registered and remaining unsold as of July 3, 2018 (the “Previously Registered Shares”) under the registrant’s registration statements on Form S-1 (No. 333-221273), as amended (the “Prior Registration Statement”), which became effective on February 9, 2018 pursuant to Section 8(a) of the Securities Act. Pursuant to Rule 429(b), this Registration Statement, upon effectiveness, also constitutes a post-effective amendment to the Prior Registration Statement, which post-effective amendment shall hereafter become effective concurrently with the effectiveness of this Registration Statement and in accordance with Section 8(c) of the Securities Act.

Title of Each Class of Securities to be Registered

Amount to be Registered⁽²⁾

Proposed Maximum Aggregate Offering Price Per Share⁽¹⁾

Proposed Maximum Aggregate Offering Price

Amount of Registration Fee

Common stock, par value $0.001 per share, Issuable pursuant to Securities Purchase Agreement⁽³⁾

320,000,000

0.0106

3,392,000

422.30

Total

320,000,000

0.0106

3,392,000

422.30

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to Section 8(a), may determine.

The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

This prospectus relates to the resale of up to 320,000,000 shares of our common stock to be offered by the selling stockholder, GHS Investments, LLC (“GHS”). These 320,000,000 shares of common stock consist of up to 320,000,000 shares of common stock issuable to GHS under the terms of a Securities Purchase Agreement dated June 27, 2018.

Our registration of the shares of common stock covered by this prospectus does not mean that the selling stockholder will offer or sell any of such shares of common stock. The selling stockholder may sell the shares of common stock covered by this prospectus in a number of different ways and at varying prices. For additional information on the possible methods of sale that may be used by the selling stockholders, you should refer to the section of this prospectus entitled “Plan of Distribution”. We will not receive any of the proceeds from the sale of common stock by the selling stockholders.

GHS is an underwriter within the meaning of the Securities Act of 1933, and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act of 1933 in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act of 1933. We will bear all costs, expenses and fees in connection with the registration of the common stock. The selling stockholder will bear all commissions and discounts, if any, attributable to its sales of our common stock.

Our common stock is quoted on the OTCQB tier of the electronic over-the-counter marketplace operated by OTC Markets Group, Inc. On ~~August 6,~~October 4, 2018, the last reported sales price for our common stock was ~~$0.0106~~$0.01276 per share.

Investment in our common stock involves risk. See “Risk Factors” contained in this prospectus. You should carefully read this prospectus, together with the documents we incorporate by reference, before you invest in our common stock.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this prospectus. Any representation to the contrary is a criminal offense.

You should rely only on the information contained in this prospectus or in any free writing prospectus thatwemay specifically authorize to be delivered or made available to you. We have not, and the underwriters have not, authorized anyone to provide you with any information other than that contained in this prospectus or in any free writing prospectuswe may authorize to be delivered or made available to you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus may only be used where it is legal to offer and sell shares of our common stock. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of shares of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date. We are not, and the selling stockholders are not, making an offer of these securities in any jurisdiction where the offer is not permitted.

For investors outside the United States: We have not and the selling stockholders have not done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States.

This summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including our financial statements and the related notes and the information set forth under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in each case included elsewhere in this prospectus.

Unless the context otherwise requires, references to “we,” “our,” “us,” or the “Company” in this prospectus mean Rocky Mountain High Brands, Inc. on a consolidated basis with its wholly-owned subsidiaries.

Rocky Mountain High Brands, Inc. is a Nevada corporation. RMHB currently operates through its parent company, four wholly-owned subsidiaries and one minority-owned subsidiary, which the Company controls. All subsidiaries are consolidated for financial reporting purposes:

RMHB is a consumer goods company that specializes in developing, manufacturing, marketing, and distributing high-quality, health conscious, cannabidiol (“CBD”) and hemp-infused products that span various categories including beverage, food, fitness, skin care and more. RMHB also markets a naturally high alkaline spring water as part of our brand portfolio.

The Company currently markets its Citrus Energy hemp-infused functional beverage. The Company also bottles and distributes its naturally high alkaline spring water under the name Eagle Spirit Spring Water.

On December 4, 2017, the Company entered into a three-year Master Manufacturer Agreement with CBD-Alimentos SA de CV (“CBD-Alimentos”), a Mexican food and beverage distributor, whereby the Company will be CBD-Alimentos’ exclusive supplier of hemp-infused beverages in Mexico. The agreement, as amended, calls for the delivery of 16,000,000 cans of CBD-infused beverages during 2018. The Company expects to begin shipments to CBD-Alimentos in the third quarter of 2018.

In March 2018, the Company launched the HEMPd brand with tinctures, gummies, water soluble drops, capsules, lotions, salves, and E-juice liquids and cartridges. The Company plans to introduce CBD-infused waters and additional HEMPd product offerings during the remainder of 2018. HEMPd products are marketed through the Company’s Wellness For Life, Inc. subsidiary. Customer shipments of HEMPd products began in late March 2018.

Rocky Mountain High Brands Inc. October 23, 2015 to present – Articles of Amendment filed with the State of Nevada

f/k/a Totally Hemp Crazy Inc. July 17, 2014 to October 23, 2015 – Articles of Amendment filed with the State of Nevada

f/k/a Republic of Texas Brands Incorporated November 2011 to July 17, 2014 – Articles of Amendment filed with the State of Nevada

f/k/a Legends Food Corporation May 2011 to November 2011 – Articles of Amendment filed with the State of Nevada

f/k/a Precious Metals Exchange Corp. – Articles of Amendment filed with the State of Nevada on December 23, 2008

f/k/a Stealth Industries, Inc. – Articles of Amendment filed with the State of Minnesota on October 25, 1999 (name change). Articles of Incorporation filed with the State of Nevada on October 30, 2000 (Change of Domicile; Merger with Stealth Industries, Inc. (Minnesota)

f/k/a Assisted Living Corporation – Articles of Amendment filed with the State of Minnesota on November 3, 1993 (name change) f/k/a Electric Reel Corporation of America, Inc. -- Articles of Incorporation filed with the State of Minnesota on August 15, 1968

In July 2016, the Company entered into a business alliance with Poafpybitty Family, LLC to launch Eagle Spirit Spring Water, a line of purified, high-alkaline spring water sourced from Native American tribal land in Oklahoma. The agreement calls for the Company to pay a royalty on each gallon of water collected at the spring. Production of filtered spring water filled bottles commenced in August 2016 and sales began in October 2016.

In consideration for the 20-year water and surface rights, and a related 10-year renewal option, the Company paid Poafpybitty Family, LLC cash payments of $22,500 and issued a warrant for 500,000 shares of the Company’s common stock exercisable at $.03 per share over a three-year period beginning July 27, 2016.

The agreement grants the Company an exclusive right to develop land adjacent to the spring for commercial purposes as agreed to by both parties. Additionally, the Company has agreed to grow hemp for experimental or commercial purposes on the land within three years.

On November 12, 2016, the agreement with the Poafpybitty Family was amended to give the Company a controlling voting interest of 75% of RMHW, while the Poafpybitty Family received 51% of the equity interest. The amended agreement is being accounted for as a step-acquisition, with the resulting goodwill of $49,911 included in other assets. The Company is obtaining an outside valuation of the rights to use the land and obtain the water described in the agreement. Beginning November 12, 2016, the operations of RMHW are consolidated in the financial statements of RMHB.

We have issued five Secured Promissory Notes to GHS in the amounts set forth below. The Notes bear interest at an annual rate of ten percent (10%), and are secured by all of our assets. Four of the Notes were exchanged with GHS on June 1, 2018 for a replacement Note containing modified terms. The due date of these notes, as extended, is currently June 1, 2019. Additional notes were entered into on July 24, August 9, and August 30, 2018, respectively. As currently issued, the amounts due as of September 5, 2018 and due dates of the Notes are as follows:

Note	Principal Amount Owing	Accrued Interest Owing	Due Date	Principal Amount Owing	Accrued Interest Owing	Due Date
First Note (originally issued 10/12/17)	$164,492.14	$4,731.97	June 1, 2019	$164,492.14	$6,038.89	June 1, 2019
Second Note (originally issued 11/2/17)	$212,328.77	$7,097.02	June 1, 2019	$212,328.77	$8,784.01	June 1, 2019
Third Note (originally issued 1/5/18)	$17,976.92	$0	June 1, 2019	$0		n/a
Fourth Note (originally issued 1/11/18)	$95,830.00	$1,638.73	June 1, 2019	$0		n/a
Fifth Note (issued July 24, 2018)	$157,500.00	$560.96	April 24, 2019	$157,500.00	$2,934.25	April 24, 2019
Sixth Note (issued August 9, 2018)	$157,500	$1,121.92	May 9, 2019	$157,500	$2,373.29	May 9, 2019
Seventh Note (issued August 30, 2018)	$105,000	$172.60	May 30, 2019	$105,000	$1,006.85	May 30, 2019
Eighth Note (issued September 14, 2018)				$131,250	$683.22	June 14, 2019
Ninth Note (issued September 28, 2018)				$55,000	$90.41	June 28, 2019
Totals	$910,627.83	$21,098.90		$983,070.91	$21,910.92

Events of default under the Notes include: (i) failure to pay installments when due, (ii) failure to timely deliver shares of common stock in the event thatwehave elected such conversion and sent notice of such to GHS, (iii) breach of representations or warranties made in the Notes, (iv) receivership, bankruptcy, or liquidation, (v) our failure to comply with the reporting requirements of the Exchange Act, and (vi) failure to maintain OTC quotation of our common stock.

In the event of our default, the GHS Note will bear interest at an annual rate of 20% and the balances due under the Notes will be accelerated. Further, a default penalty of 50% will apply to the outstanding balances and GHSmay,as a secured creditor, enforce its lien on our assets and liquidate them under Article 9 of the Uniform Commercial Code. The Notes are not currently in default. Although the Notes were originally convertible at a price of $0.008 per share, the conversion price has adjusted to $0.005 per share in accord with certain adjustment provisions set forth in the Notes. The Notes are currently convertible at $0.005 per share. This conversion price will remain in effect during the remaining life of the Notes. GHS’s ability to convert the Notes is limited such that: (i) no conversion may be effected to the extent that, following such conversion, GHS would own more that 9.99% of our issued and outstanding common stock; and (ii) for so long aswe are not in default under any of the Notes, GHS may not convert, in any calendar month, any portion of a Note in excess of $50,000. In addition, for so long asweare not in default under any of the Notes, GHS may not, on any individual trading day, re-sell an amount of shares of common stock received upon conversion of all Notes that is in excess of fifteen percent (15%) of the total trading volume for such trading day.

On October 12, 2017, we entered into an Equity Financing Agreement with GHS which provided for GHS’s purchase of up to $12,000,000 of our common stock (the “prior EFA”). Effective February 9, 2018, we registered GHS’s resale of up to 250,000,000 shares of common stock to be purchased under the prior EFA. Between February 12, 2018 and June 21, 2018, we have put a total of 244,217,685 shares to GHS under the prior EFA, for total proceeds to the Company of $2,514,561. Our average sale price to GHS for shares put under the prior EFA was $0.0106 per share. There are 5,782,315 remaining shares which may be put to GHS under the prior EFA and resold pursuant to the registration statement effective February 9, 2018 .

On June 27, 2018, we entered into a new Securities Purchase Agreement with GHS which provides for GHS’s purchase of up to $15,000,000 worth of our common stock (the “SPA”). We are registering for resale by GHS up to 320,000,000 shares of common stock to be purchased by GHS under the SPA. Under the SPA, GHS has agreed to purchase up to $15,000,000 worth of our common stock over the next twenty-four (24) months. Sales of common stock to GHS under SPA shall be initiated from time to time by our issuance of individual Put Notices to GHS. The price of shares put to GHS under each Put Notice shall be eighty-two (82%) percent of the “Market Price,” which is the lowest traded price of our common stock during the ten (10) consecutive trading days preceding the date of the Put Notice. However, in the event that (i) the lowest volume-weighted average price (“VWAP”) of our common stock for any given trading day during the ten (10) trading days following a Put Notice (the “Trading Period”) is less than 82% of the Market Price used to determine the Purchase Price in connection with the Put and (ii) as of the end of such Trading Period, GHS still holds shares issued pursuant to such Put Notice (the “Trading Period Shares”), then we will be required to issue such additional shares of common stock, on the trading day immediately following the Trading Period, as may be necessary to adjust the Purchase Price for that portion of the Put represented by the Trading Period Shares to equal the lowest VWAP during the Trading Period.

The amount and timing of each Put Notice will be subject to certain limitations: (i) a new Put Notice may not be issued until the prior put has closed, (ii) there must be aminimumof eight (8) trading days between each Put Notice, (iii) no Put Notice will be effective to the extent that, following the closing of the put, GHS and its affiliates would own more than 9.99% of our common stock; (iv) themaximumdollar amount of each put will not exceedtwotimes (2x) the average of the daily trading dollar volume for our common stock during the ten (10) trading days preceding the put date; and (v) no put will be made in an amount greater than five hundred thousand dollars ($500,000).

Our ability to use the SPA facility is conditioned upon, among other things, the effectiveness of a registration statement registering the resale by GHS of the shares of common stock issuable under the SPA. Our obligations in this regard are governed by a Registration Rights Agreement with GHS dated June ~~__,~~27, 2018 (the “RRA”). The RRA requires us to file a Registration Statement for GHS’s resale of the Registrable Securities with thirty (30) days, and to use our best efforts to secure effectiveness of the Registration Statement with ninety (90) days after filing. Once the Registration Statement is effective, we are required to maintain its effectiveness, by appropriate amendments and/or prospectus supplements, until the earlier to occur of the following: (A) GHS has sold all the Registrable Securities; or (B) GHS has no right to acquire any additional shares of common stock under the SPA.

A total of 320,000,000 shares issuable under the SPA are being offered under this Prospectus. At a price of $.00968 (82% of our market price as of June 5, 2018), a sale of all of these shares to GHS would represent total proceeds to us of $3,096,320. Our actual sale prices to GHS, however, will be determined by reference to the trading price of our common stock in the market, with GHS receiving a discount from the market trading price as indicated above. Because market prices of our common stock are subject to constant fluctuations, the actual amount to be received by us upon sale of the 320,000,000 shares being offered could vary substantially from the listed offering amount for shares issuable under the SPA. If our stock price were to decrease, the total proceeds available to us upon sale of the shares being offered under this Prospectus could correspondingly decrease substantially. Please see “Future Liquidity Requirements” on page 20 for an illustration of the total proceeds which would be received under a range of assumed trading prices.

Our principal executive offices are located at 9101 LBJ Freeway, Suite 200, Dallas, TX 75243. Our telephone number is (800) 260-9062. The Company’s website address ishttp://www.rockymountainhighbrands.com. Information contained on the Company’s website is not incorporated into this prospectus. Annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports are available free of charge through the Securities and Exchange Commission (“SEC”) website athttp://www.sec.gov as soon as reasonably practicable after those reports are electronically filed with or furnished to the SEC. These reports are also available on the Company’s website.

Common stock offered by the selling shareholder		320,000,000 shares of common stock, consisting of up to 320,000,000 shares of common stock issuable to GHS under the terms of a Securities Purchase Agreement dated June 27, 2018.

Common stock to be outstanding after this offering		~~1,949,825,101~~ 2,039,504,073shares, assuming all shares issuable to GHS under the Securities Purchase Agreement are issued by us.

Use of proceeds		We will not receive any proceeds from the sale of the common stock offered by the selling stockholders.

Risk factors		See “Risk Factors” beginning on page 10 of this prospectus and the other information included in this prospectus for a discussion of factors you should carefully consider before investing in our securities.

OTCQB trading symbol		RMHB

Unless we indicate otherwise, all information in this prospectus is based on ~~1,629,825,101~~1,719,504,072 shares of common stock issued and outstanding as of ~~June 20,~~October 4, 2018, and excludes shares issuable upon conversion of convertible notes and shares issuable upon the conversion of outstanding warrants and options .

Investing in our common stock involves a high degree of risk. Prospective investors should carefully consider the risks described below and other information contained in this prospectus, including our financial statements and related notes before purchasing shares of our common stock. There are numerous and varied risks, known and unknown, that may prevent us from achieving our goals. If any of these risks actually occurs, our business, financial condition or results of operations may be materially adversely affected. In that case, the trading price of our common stock could decline and investors in our common stock could lose all or part of their investment.

We have a limited operating history and operate in a new industry, and we may not succeed.

The hemp oil and beverage businesses are highly competitive and risky, and competition from companies much bigger than us could adversely affect our operating results.

We compete with many national, regional and local businesses. We could experience increased competition from existing or new companies in the hemp oil and beverage channels, which could create increasing pressures to grow ours. If we are unable to maintain our competitive position, we could experience downward pressure on prices, lower demand for our products, reduced margins, the inability to take advantage of new business opportunities and the loss of channel share, which would have an adverse effect on our operating results. Other factors that could affect our business are:

We may fail to successfully implement our growth strategy, which includes direct-to-consumer as well as brick and mortar channels.

Our success as a national brand requires that we successfully compete online through our proprietary websites, Amazon, and eBay and place our products in national and local retailers through our distribution network. Failure to achieve sales in any of these areas will have an adverse effect on our growth.

The hemp oil and beverage industries are affected by consumer preferences and perceptions. Changes in these preferences and perceptions may lessen the demand for our products, which would reduce sales and harm our business.

The hemp oil and beverage businesses are affected by changes in consumer tastes, national, regional and local economic conditions, and demographic trends. If consumer demand for our brand categories should decrease, our business would suffer.

Increases in the cost of ingredients and raw materials could materially affect our operating results.

Our principal products contain hemp oil. Increases in the cost of hemp oil as well as other ingredients such as natural sweeteners, or other raw materials such as aluminum, which we use for our beverage cans, could have a material adverse effect on our operating results. Significant price increases, market conditions, weather, acts of God and other disasters could materially affect our operating results.

Increases in ingredients, raw materials, labor, and other costs could adversely affect our profitability and operating results.

An increase in our operating costs could adversely affect our profitability. Factors such as inflation, poor hemp harvests, increased labor costs, and increased energy costs may adversely affect our operating profits. Many of the factors affecting costs are beyond our control and we may not be able to pass these increased costs along to our customers.

We do not have long-term contracts with our suppliers, and as a result they could seek to significantly increase prices or fail to deliver.

We typically do not rely on long-term arrangements with our suppliers. Althoughwehave not experienced significant problems with our suppliers, our suppliers may implement significant price increases or may not meet our requirements in a timely fashion, if at all. The occurrence of any of the foregoing could have a material adverse effect on our operating results.

Any prolonged disruption in the operations of any of our co-packing and fulfillment facilities could harm our business.

We generally operate through co-packing and fulfillment agreements. All of our hemp oil-based gummies, capsules, tinctures, water soluble drops, and vape products are produced by co-packers in Colorado and direct-to-consumer orders are filled through a third-party fulfillment company in Florida. Our upcoming newly-formulated beverage products will be co-packed at yet-to-be-determined third-party production facilities. As a result, any prolonged disruption in the operations of any of these facilities, whether due to technical or labor difficulties, destruction or damage to the facility, real estate issues or other reasons, could result in increased costs and reduced revenues and our profitability and prospects could be harmed.

Loss of key personnel or our inability to attract and retain new qualified personnel could hurt our business and inhibit our ability to operate and grow successfully.

Our ability to successfully grow our brands hinges on our ability to attract and retain professionals with talent, integrity, enthusiasm and loyalty. If we are unable to attract or retain key personnel, our profitability and growth potential could be harmed.

We may not be able to adequately protect our intellectual property, which could harm the value of our brands and branded products and adversely affect our business.

We depend in large part on our brands and branded products and believe that they are very important to our business, as well as on our proprietary hemp infused processes. We rely on a combination of trademarks, copyrights, service marks, trade secrets and similar intellectual property rights to protect our brand and branded products. The success of our business depends on our continued ability to use our existing trademarks and service marks in order to increase brand awareness and further develop our branded products in both domestic and international markets. We have registered certain trademarks and have other trademark registrations pending in the United States. We may not be able to adequately protect our trademarks and our use of these trademarks may result in liability for trademark infringement, trademark dilution or unfair competition. We may from time to time be required to institute litigation to enforce our trademarks or other intellectual property rights, or to protect our trade secrets. Such litigation could result in substantial costs and diversion of resources and could negatively affect our sales, profitability and prospects regardless of whetherweare able to successfully enforce our rights.

We are subject to extensive government regulation, and our failure to comply with existing or increased regulations could adversely affect our business and operating results. We are subject to numerous federal, state, local and foreign laws and regulations, including those relating to:

Our annual and quarterly financial results are subject to significant fluctuations depending on various factors, many of which are beyond our control, which could adversely affect our ability to satisfy our debt obligations as they become due.

Our sales and operating results can vary significantly from quarter to quarter and year to year depending on various factors, many of which are beyond our control. These factors include:

Consequently, our results of operations may decline quickly and significantly in response to changes in order patterns or rapid decreases in demand for our products. We anticipate that fluctuations in operating results will continue in the future. The Company's operating results may vary. We may incur net losses. The Company expects to experience variability in its revenues and net income. While we intend to implement our business plan to the fullest extent we can, we may experience net losses.

You should further consider, among other factors, our prospects for success in light of the risks and uncertainties encountered by companies that, like us, are in their early stages. For example, unanticipated expenses, problems, and technical difficulties may occur and they may result in material delays in the operation of our business, in particular with respect to our new products. We may not successfully address these risks and uncertainties or successfully implement our operating strategies. If we fail to do so, it could materially harm our business to the point of having to cease operations and could impair the value of our common stock to the point investors may lose their entire investment.

These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern.

We will require additional capital to finance our operations in the future, but that capital may not be available when it is needed and could be dilutive to existing stockholders.

We will require additional capital for future operations. We estimate those requirements to approximate $2,000,000. We plan to finance operations and capital requirements with funds generated from the following sources:

Current conditions in the capital markets are such that traditional sources of capital may not be available to us when needed or may be available only on unfavorable terms. Our ability to raise additional capital, if needed, will depend on conditions in the capital markets, economic conditions and a number of other factors, many of which are outside our control, and on our financial performance. Accordingly,wecannot assure you thatwewill be able to successfully raise additional capital at all or on terms that are acceptable to us. Ifwecannot raise additional capital when needed, it may have a material adverse effect on our liquidity, financial condition, results of operations and prospects. Further, ifweraise capital by issuing stock, the holdings of our existing stockholders will be diluted.

If we raise capital by issuing debt securities, such debt securities would rank senior to our common stock upon our bankruptcy or liquidation. In addition, we may raise capital by issuing equity securities that may be senior to our common stock for the purposes of dividend and liquidating distributions, which may adversely affect the market price of our common stock. Finally, upon bankruptcy or liquidation, holders of our debt securities and shares of preferred stock and lenders with respect to other borrowings will receive a distribution of our available assets prior to the holders of our common stock. Additional equity offerings may dilute the holdings of our existing stockholders or reduce the market price of our common stock, or both.

Our stock price has been extremely volatile and our common stock is not listed on a national stock exchange; as a result, stockholders may not be able to resell their shares at or above the price paid for them.

The market price of our common stock has been extremely volatile and could be subject to significant fluctuations due to changes in sentiment in the market regarding our operations or business prospects, among other factors. Further, our common stock is not listed on a national stock exchange; we intend to list the common stock on a national stock exchange once we meet the entry criteria. An active public market for our common stock currently exists on the OTC Markets (www.otcmarkets.com) but may not be sustained. Therefore, stockholders may not be able to sell their shares at or above the price they paid for them.

Actual or anticipated fluctuations in our quarterly financial and operating results and operating results that vary from the expectations of our management or of securities analysts and investors

Sales by our stockholders of a substantial number of shares of our common stock in the public market could adversely affect the market price of our common stock.

A substantial portion of our total outstanding shares of common stock may be sold into the market at any time. Some of these shares are owned by executive officers and directors, andwebelieve that such holders have no current intention to sell a significant number of shares of our stock. If all of the major stockholders were to decide to sell large amounts of stock over a short period of time such sales could cause the market price of our common stock to drop significantly, even if our business is doing well.

Pursuant to Section 107(b) of the JOBS Act,wehave elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(2) of The JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result, our financial statements may not be comparable to companies that comply with public company effective dates, and our stockholders and potential investors may have difficulty in analyzing our operating results if comparing us to such companies.

We have committed, and expect to continue to commit, significant resources and capital to develop and market existing product enhancements and new products. These products are relatively untested, andwecannot assure you thatwewill achieve market acceptance for these products, or other new products thatwemay offer in the future. Moreover, these and other new products may be subject to significant competition with offerings by new and existing competitors. In addition, new products and enhancements may pose a variety of technical challenges and require us to attract additional qualified employees. The failure to successfully develop and market these new products or enhancements could seriously harm our business, financial condition and results of operations.

We are substantially dependent on continued market acceptance of our products by consumers. Althoughwebelieve that our products in the United States are gaining better consumer acceptance,wecannot predict the future growth rate and size of this market.

If we are able to expand our operations, we may be unable to successfully manage our future growth.

Since we initiated product sales in 2015, we have added additional subsidiaries and product lines. These additions have placed substantial strain on our management, operational, financial and other resources. If we are able to continue expanding our operations in the United States and in other countries where we believe our products will be successful, as planned, we may experience periods of rapid growth, which will require additional resources. Any such growth could place increased strain on our management, operational, financial and other resources, and we will need to train, motivate, and manage employees, as well as attract management, sales, finance and accounting, international, technical, and other professionals. In addition, we will need to expand the scope of our infrastructure and our physical resources. Any failure to expand these areas and implement appropriate procedures and controls in an efficient manner and at a pace consistent with our business objectives could have a material adverse effect on our business and results of operations.

Any future litigation could have a material adverse impact on our results of operations, and financial condition and liquidity. The company holds Directors & Officers insurance with a liability limit of $2,000,000, which may not be sufficient to cover a claim.

Despite our significant efforts in quality control and preservation, we will face risks of litigation from customers, employees and others in the ordinary course of business, which may divert our financial and management resources. Any adverse litigation or publicity may negatively impact our financial condition and results of operations.

Claims of illness or injury relating to food and beverage quality or handling are common in our industry. Whilewebelieve our co-packer and fulfillment partners processes and high standards of quality control will minimize these instances, there is always a risk of occurrence, and so despite our best efforts to regulate quality control, litigation may occur. In that event, our financial condition, operating results and cash flows could be harmed.

From time to time we may be subject to litigation, including potential stockholder derivative actions. Risks associated with legal liability are difficult to assess and quantify, and their existence and magnitude can remain unknown for significant periods of time. The Company holds Directors & Officers insurance with a liability limit of $2,000,000, which may not be sufficient to cover a potential claim. While neither Nevada law nor our articles of incorporation or bylaws require us to indemnify or advance expenses to our officers and directors involved in such a legal action, we expect that we would do so to the extent permitted by Nevada law.

You should not consider prior operating results with respect to revenues, net income, or any other measure to be indicative of our future operating results. The timing and amount of future revenues will depend almost entirely on our ability to sell our products to new customers. Our future operating results will depend upon many other factors, including:

We have only two outside Board Directors, which could create conflicts of interests and pose risks from a corporate governance perspective.

Our Board of Directors consists primarily of current executive officers, which means thatwehave only two outside or independent directors. The lack of independent directors may prevent the Board from being independent from management in its judgments and decisions and its ability to pursue the Board responsibilities without undue influence. For example, an independent Board can serve as a check on management, which can limit management taking unnecessary risks. Furthermore, the lack of a sufficient number of independent directors creates the potential for conflicts between management and the diligent independent decision making process of the Board. In this regard, our lack of an independent compensation committee presents the risk that our executive officers on the Board may have influence over his/their personal compensation and benefits levels that may not be commensurate with our financial performance. Furthermore, our lack of outside directors deprives our company of the benefits of various viewpoints and experience when confronting the challengesweface. With only two independent directors on the Board of Directors, it will be difficult for the Board to fulfill its traditional role as overseeing management.

Our preferred stock may have rights senior to those of our common stock which could adversely affect holders of common stock.

Our articles of incorporation give our Board of Directors the authority to issue additional series of preferred stock without a vote or action by our stockholders. The Board also has the authority to determine the terms of preferred stock, including price, preferences, and voting rights. The rights granted to holders of preferred stock in the future may adversely affect the rights of holders of our common stock. Any such authorized class of preferred stock may have a liquidation preference – a pre-set distribution in the event of a liquidation – that would reduce the amount available for distribution to holders of common stock or superior dividend rights that would reduce the amount of dividends that could be distributed to common stockholders. In addition, an authorized class of preferred stock may have voting rights that are superior to the voting rights of the holders of our common stock.

We are an emerging growth company and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies, our common stock may be less attractive to investors.

We are an emerging growth company, as defined in the JOBS Act, andweare eligible to take advantage of certain exemptions from various reporting requirements applicable to other public companies, but not to emerging growth companies, including, but not limited to, a requirement to present onlytwoyears of audited financial statements, an exemption from the auditor attestation requirement of Section 404 of the Sarbanes-Oxley Act, reduced disclosure about executive compensation arrangements pursuant to the rules applicable to smaller reporting companies and no requirement to seek non-binding advisory votes on executive compensation or golden parachute arrangements, although some of these exemptions are available to us as a smaller reporting company (i.e. a company with less than $75 million of its voting equity held by non-affiliates). We have elected to adopt these reduced disclosure requirements. We cannot predict if investors will find our common stock less attractive as a result of our taking advantage of these exemptions. If some investors find our common stock less attractive as a result of our choices, there may be a less active trading market for our common stock and our stock price may be more volatile.

We intend to retain our future earnings, if any, in order to reinvest in the development and growth of our business and, therefore, do not intend to pay dividends on our common stock for the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, and such other factors as our board of directors deems relevant. Accordingly, investors may need to sell their shares of our common stock to realize a return on their investment, and they may not be able to sell such shares at or above the price paid for them.

We can sell additional shares of common stock without consulting stockholders and without offering shares to existing stockholders, which would result in dilution of existing stockholders’ interests in RMHB and could depress our stock price.

Our Articles of Incorporation, as amended, authorize 4,000,000,000 shares of common stock, of which 1,629,825,101 are outstanding as of June 5, 2018; 1,000,000 shares of series A preferred stock, of which 1,000,000 shares are outstanding; 5,000,000 shares of series B preferred stock, of which 0 shares are outstanding; 2,000,000 shares of series C preferred stock, of which 0 shares are outstanding; 2,000,000 of series D preferred stock, none of which are issued and outstanding; and 789,474 shares of Series E Preferred Stock, none of which are issued and outstanding. Our Board of Directors is authorized to issue additional shares of our common stock and preferred stock. Although our Board of Directors intends to utilize its reasonable business judgment to fulfill its fiduciary obligations to our then existing stockholders in connection with any future issuance of our capital stock, the future issuance of additional shares of our common stock or preferred stock convertible into common stock would cause immediate, and potentially substantial, dilution to our existing stockholders, which could also have a material effect on the market value of the shares.

Further, our shares do not have preemptive rights, which mean we can sell shares of our common stock to other persons without offering purchasers in this offering the right to purchase their proportionate share of such offered shares. Therefore, any additional sales of stock by us could dilute an existing stockholder’s ownership interest in our company.

We may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock. Although no assurances can be given that we will consummate a financing, in the event we do, or in the event we sell shares of common stock or other securities convertible into shares of our common stock in the future, additional and substantial dilution will occur. In addition, investors purchasing shares or other securities in the future could have rights superior to investors in this offering.

This prospectus contains forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. These forward-looking statements are based on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such statements.

In some cases, you can identify forward-looking statements by terminology, such as “expects”, “anticipates”, “intends”, “estimates”, “plans”, “potential”, “possible”, “probable”, “believes”, “seeks”, “may”, “will”, “should”, “could” or the negative of such terms or other similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this prospectus.

You should read this prospectus and the documents thatwereference herein and therein and have filed as exhibits to the registration statement, of which this prospectus is part, completely and with the understanding that our actual future results may be materially different from whatweexpect. You should assume that the information appearing in this prospectus is accurate as of the date on the front cover of this prospectus only. Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. These risks and uncertainties, along with others, are described above under the heading “Risk Factors” beginning on page 10 of this prospectus. Further, any forward-looking statement speaks only as of the date on which it is made, andweundertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition,wecannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this prospectus, and particularly our forward-looking statements, by these cautionary statements.

Unless the context otherwise requires, as used in this prospectus, “selling stockholder” refers to GHS Investments, LLC.

We have prepared this prospectus to allow the selling stockholder to sell or otherwise dispose of, from time to time, up to 320,000,000 shares of our common stock. The 320,000,000 shares of common stock to be offered hereby are issuable to the selling stockholder in connection with the Securities Purchase Agreement with the Selling Stockholder.

No estimate can be given as to the amount or percentage of common stock that will be held by the selling stockholder after any sales made pursuant to this prospectus because the selling stockholder is not required to sell any of the common stock being registered under this prospectus. The following table assumes that the selling stockholder will sell all of the common stock listed in this prospectus.

Unless otherwise indicated in the footnotes below, the selling stockholder has not had any material relationship with us or any of our affiliates within the past three years other than as a security holder.

Unless otherwise indicated in the footnotes below, we believe that: (1) the selling stockholder is not a broker-dealer or affiliate of any broker-dealer, (2) the selling stockholder does not have direct or indirect agreements or understandings with any person to distribute the common stock, and (3) the selling stockholder has sole voting and investment power with respect to all common stock beneficially owned.

GHS will be deemed to be an underwriter within the meaning of the Securities Act. Any profits realized by the selling stockholder may be deemed to be underwriting commissions.

The following table sets forth information with respect to the beneficial ownership of our common stock held, as of July 3, 2018, by the selling stockholder and the number of shares of common stock being registered hereby and information with respect to shares to be beneficially owned by the selling stockholder after completion of the offering of the shares for resale. The percentages in the following table reflect the shares beneficially owned by the selling stockholder as a percentage of the total number of shares of common stock outstanding as of ~~July 3,~~October 4, 2018. As of such date, ~~1,629,967,551~~1,719,504,073 shares of common stock were outstanding.

Our common stock is quoted on the OTCQB tier of the OTC Markets Group quotation system (www.otcmarkets.com) under the trading ticker “RMHB.” The following tables set forth the range of high and low prices for our common stock for the two years ended June 30, 2017 and the ~~six~~nine months ended ~~December 31, 2017,~~September 30, 2018, as reported on the OTC Market Group’s quotation system. These quotations reflect inter-dealer prices, without retail markup, markdown, or commission and may not necessarily represent actual transactions.

Quarter Ended:	Quarter Ended:	High Sale Price		Low Sale Price		Quarter Ended:	High Sale Price		Low Sale Price
March 31, 2016		$	0.10	$	0.06		$	0.10	$	0.06
June 30, 2016		$	0.10	$	0.03		$	0.10	$	0.03
September 30, 2016		$	0.04	$	0.03		$	0.04	$	0.03
December 31, 2016		$	0.07	$	0.03		$	0.07	$	0.03
March 31, 2017		$	0.15	$	0.04		$	0.15	$	0.04
June 30, 2017		$	0.10	$	0.07		$	0.10	$	0.07
September 30, 2017		$	0.07	$	0.02		$	0.07	$	0.02
December 31, 2017		$	0.03	$	0.01		$	0.03	$	0.01
March 31, 2018		$	0.03	$	0.01		$	0.03	$	0.01
June 30, 2018		$	0.02	$	0.01		$	0.02	$	0.01
September 30, 2018							$	0.01	$	0.01

On ~~September~~October 4, 2018, the last sales price per share of our common stock was ~~$0.0119.~~$0.01276.

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a market price of less than $5.00, other than securities registered on certain national securities exchanges or quoted on the NASDAQ system, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the SEC, that: (a) contains a description of the nature and level of risk in the market for penny stocks in both public offerings and secondary trading; (b) contains a description of the broker's or dealer's duties to the customer and of the rights and remedies available to the customer with respect to a violation of such duties or other requirements of the securities laws; (c) contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price; (d) contains a toll-free telephone number for inquiries on disciplinary actions; (e) defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and (f) contains such other information and is in such form, including language, type size and format, as the SEC shall require by rule or regulation.

The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with (a) bid and offer quotations for the penny stock; (b) the compensation of the broker-dealer and its salesperson in the transaction; (c) the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and (d) a monthly account statement showing the market value of each penny stock held in the customer's account.

In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written acknowledgment of the receipt of a risk disclosure statement, a written agreement as to transactions involving penny stocks, and a signed and dated copy of a written suitability statement.

These disclosure requirements may have the effect of reducing the trading activity for our common stock. Therefore, stockholders may have difficulty selling our securities.

As of ~~July 5,~~October 4, 2018 there were approximately ~~23,000~~273 holders of record of our common stock.

On March 17, 2017, our Board of Directors approved the Rocky Mountain High Brands, Inc. 2017 Incentive Plan (the “2017 Incentive Plan”). The purpose of the Incentive Plan is to provide a means for the Company to continue to attract, motivate and retain management, key employees, consultants and other independent contractors, and to provide these individuals with greater incentive for their service to the Company by linking their interests in the Company’s success with those of the Company and its shareholders. The Plan provides that up to amaximumof 35,000,000 shares of the Company’s common stock (subject to adjustment) are available for issuance under the Plan. The Board of Directors awards these shares at its sole discretion.

Also on March 31, 2017, certain of our officers and directors returned a total of 25,041,732 shares of common stock to treasury for cancellation. On that same date, we granted to each of these officers and directors an equivalent number of restricted shares of common stock under our 2017 Incentive Plan. The restricted shares so granted may not be transferred, sold, or encumbered until six (6) months from the date of issue.

In April and June 2017, a Board member was granted 7,000,000 and 13,000,000 options to purchase common stock, respectively. In May 2017 another Board member was granted 7,000,000 options. An additional 350,000 options were granted to a consultant to the Company in April 2017. All options were granted through the 2017 Incentive Plan.

On July 14, 2017 the Board of Directors increased the authorized shares in the 2017 Incentive Plan to 65,000,000.

On December 19, 2017 the Board of Directors increased the authorized shares in the 2017 Incentive Plan to 100,000,000 and issued 33,100,000 options to members of the Board, management and employees.

There are no restrictions in our articles of incorporation or bylaws that prevent us from declaring dividends. The Nevada Revised Statutes, however, do prohibit us from declaring dividends where after giving effect to the distribution of the dividend:

1. Wewould not be able to pay our debts as they become due in the usual course of business, or;

2. Our total assets would be less than the sum of our total liabilities plus the amount that would be needed to satisfy the rights of shareholderswhohave preferential rights superior to those receiving the distribution.

We have not declared any dividends and we do not plan to declare any dividends in the foreseeable future.

The sale of our common stock to GHS in accordance with the Securities Purchase Agreement may have a dilutive impact on our shareholders. As a result, our net income per share could decrease in future periods and the market price of our common stock could decline. In addition, the lower our stock price is at the time we exercise our put option, the more shares of our common stock we will have to issue to GHS. If our stock price decreases, then our existing shareholders would experience greater dilution for any given dollar amount raised through the offering.

The perceived risk of dilution may cause our stockholders to sell their shares, which would contribute to a decline in the price of our common stock. Moreover, the perceived risk of dilution and the resulting downward pressure on our stock price could encourage investors to engage in short sales of our common stock. By increasing the number of shares offered for sale, material amounts of short selling could further contribute to progressive price declines in our common stock.

Dilution represents the difference between the offering price (market price) and the net tangible book value per share immediately after completion of this Offering. Net tangible book value is the amount that results from subtracting total liabilities and intangible assets (product development costs) from total assets. Dilution arises mainly as a result of our arbitrary determination of the Offering price of the shares being offered. Dilution of the value of the shares you purchase is also a result of the lower book value of shares of our common stock held by our existing shareholders.

As of March 31, 2018, the net tangible book value of our shares of common stock was ($1,016,684), or approximately ($0.0) per share based upon 1,509,279,945 shares then outstanding. Upon completion of this Offering, if 100% of the shares are sold (320,000,000 shares) at a discounted market price of $0.01 (82% of $0.012 market price) per share, the net tangible book value of the 1,829,279,945 shares to be outstanding will be approximately $2,079,636 or approximately $0.0 per share. Based on these figures, current shareholders will not experience a dilution in terms of net tangible book value per share as a result of this offering.

The following discussion and analysis of financial condition and results of operations should be read together with our financial statements and accompanying notes appearing elsewhere in this Prospectus. This Management’s Discussion and Analysis contains forward-looking statements that involve risks and uncertainties. Please see “Forward-Looking Statements” set forth in the beginning of this Prospectus, and see “Risk Factors” beginning on page 10 for a discussion of certain risk factors applicable to our business, financial condition, and results of operations. Operating results are not necessarily indicative of results that may occur in future periods.

The Company generates revenue from finished product sales to distributors (resellers), retailers and consumers. The wholesale market for the Company’s products includes all retailers in the convenience and grocery store channels as well as a number of specialty retail niche markets including health food, “smoke shop,” and novelty stores. Additionally, the Company has an online retail presence on Amazon.com and via our Company websites.

Six Months Ended December 31, 2017 Compared to Six Months Ended December 31, 2016

The Company’s sales for the six months ended December 31, 2017 were $59,653 compared to $320,338 for the six months ended December 31, 2016.

The Company’s net loss for the six months ended December 31, 2017 was $5,507,781 compared to a net loss of $3,140,693 for the six months ended December 31, 2016.

For the six months ended December 31, 2017, sales were $59,653 compared to $320,338 for the six months ended December 31, 2016, a decrease of $260,685 or 81%. The sales decrease was driven primarily by the lack of funding for inventory production, direct sales support, and advertising and promotion of the Company’s products. Also, in 2017 the Company has reduced prices on its existing drinks and shots inventory in order to clear out existing inventory and prepare for the launch of its new HEMPd product line. The prior year sales amount included a large sale to a distributor. In the six months ended December 31, 2017 sales consisted of approximately 68% online sales, 22% retailer sales, and 10% distributor sales, compared to 97% distributor sales and 3% online sales for the six months ended December 31, 2016.

For the six months ended December 31, 2017, cost of sales was $173,043 or 290% of sales, versus $127,476 or 40% of sales for the six months ended December 31, 2016, an increase of $45,567 or 36%. In 2017 the Company recorded inventory obsolescence expense of $93,110 compared to $28,837 in 2016, resulting in a high cost of sales percentage. In 2017 the obsolescence expense was comprised of the write-down of the remaining hemp-infused beverage and shots inventoryto reflect selling price reductions. In 2016,the obsolescence expense was due to the write-off of the Company’s expired brownie inventory.

For the six months ended December 31, 2017, operating expenses were $2,744,840 or 4,601% of sales, compared to $2,602,148 or 812% of sales for the six months ended December 31, 2016, an increase of $142,692 or 6%. Areas in which the Company experienced significant changes in operating expenses are discussed below.

For the six months ended December 31, 2017, general and administrative expenses were $2,567,486 or 4,304% of sales, compared to $1,853,089 or 579% of sales for the six months ended December 31, 2016, an increase of $714,397 or 39%. The increase in general and administrative expenses in 2017 was driven by fees and penalties paid on convertible debt.

For the six months ended December 31, 2017, advertising and marketing expenses were $118,191 or 198% of sales, compared to $749,059 or 234% of sales for the six months ended December 31, 2016, a decrease of $630,868 or 84%. The decrease in advertising and marketing expenses in 2017 was driven by the lack of funding for advertising and promotional expenditures and the decreased need to advertise and promote the Company’s existing products in anticipation of the launch of the new product line.

During the six months ended December 31, 2017, the Company recorded an impairment expense of $59,163 related to its investment in Rocky Mountain High Water Company. This represented a 100% impairment on this investment. There was no impairment recorded during the six months ended December 31, 2016.

For the six months ended December 31, 2017, interest expense was $2,054,438, compared to $398,648 for the six months ended December 31, 2016, an increase of $1,655,790 or 415%. The increase in interest expense, which includes the amortization of the discount on convertible debt, beneficial conversion features on convertible debt, interest on Series C Preferred Stock, and interest on newly issued convertible debt was due to increased debt activity in 2017.

For the six months ended December 31, 2017, the Company recorded a gain of $1,200,092 on the extinguishment of debt. The gain was a result of the legal settlement related to certain notes, the amendment of two convertible notes into non-convertible notes, and the conversion of certain convertible notes payable involving derivative liabilities into stock. There was no change gain or loss on the extinguishment of debt during the six months ended December 31, 2016.

For the six months ended December 31, 2017, the Company recorded a loss on the change in fair value of derivative liability of $1,795,205 compared to a loss of $332,759 during the six months ended December 31, 2016. In 2017 the loss resulted from the increase in convertible debt and the related increase in the value of the conversion features, partially offset by the decrease in the price of the Company’s underlying stock, which is used to calculate the fair value of the related derivative liability, over the period from July 1, 2017 to December 31, 2017. The smaller loss in 2016 resulted from the relative stability of the price of the Company’s common stock between July 1, 2016 and December 31, 2017.

For the six months ended December 31, 2017 and 2016, the Company recorded no income tax benefit due to a full valuation allowance provided on deferred tax assets resulting from net operating losses.

As of December 31, 2017, we had current assets of $736,861, consisting of cash of $16,983, accounts receivable (net) of $2,844, inventory of $82,312, and prepaid expenses and other current assets of $634,722. As of December 31, 2017, we had current liabilities of $7,843,534, consisting of accounts payable and accrued liabilities of $750,807, related party convertible notes payable (net) of $174,456, convertible notes payable (net) of $677,698, other notes payable of $549,936, accrued interest of $81,248, and derivative liability of $5,609,389. During the six months ended December 31, 2017, the Company received proceeds of $760,000 from the issuance of debt and $8,500 related to a private offering stock sale of 500,000 shares of common stock. The selling price of the common stock was $.017 per share.

Net cash used in operating activities during the six months ended December 31, 2017 and 2016 was $836,334 and $789,802, respectively. In both periods, the Company used funds for freight, storage, and administrative expenses.

Net cash used in investing activities during the six months ended December 31, 2017 and 2016 was $664 and $76,409, respectively. In 2017 the Company expended $1,496 for computer and office equipment compared to $36,635 for vehicles in 2016. In 2016 the Company also invested $39,774 in Rocky Mountain High Water Company.

Net cash provided by financing activities during the six months ended December 31, 2017 and 2016 was $762,306 and $919,017, respectively. In 2017 debt issuances provided $760,000 and common stock sales provided $8,500. Also in 2017, the Company made payments on debt totaling $6,194. In 2016 common stock sales provided $456,650 and debt issuances provided $466,560. Also in 2016, the Company made payments on debt totaling $4,193.

The Company’s sales for the year ended June 30, 2017 were $401,974 compared to $1,075,476 for the year ended June 30, 2016.

The Company’s net loss for the year ended June 30, 2017 was $9,276,251 compared to net income of $2,325,726 for the year ended June 30, 2016.

For the year ended June 30, 2017, sales were $401,974 compared to $1,075,476 for the year ended June 30, 2016, a decrease of $673,502 or 63%. The sales decrease was driven by the lack of funding for inventory production, direct sales support, and advertising and promotion of the Company’s products, as well as a restructuring of our outside broker agreements, and product returns. In the year ended June 30, 2017 sales consisted of approximately 80% distributor sales and 20% online sales, compared to 93% distributor sales and 7% online sales for the year ended June 30, 2016.

For the year ended June 30, 2017, cost of sales was $251,920 or 63% of sales, versus $1,134,636 or 105% of sales for the year ended June 30, 2016, a decrease of $882,716 or 78 %. In 2017 the Company recorded inventory obsolescence expense of $100,998 compared to $725,718 in 2016, resulting in a lower cost of sales percentage. In 2017 the obsolescence expense was comprised of a $72,161 write-off of the remaining “mountain can” packaging and a $28,837 write-off of the Company’s expired brownie inventory. In 2016 the obsolescence expense related primarily to expiring hemp-infused beverage product.

For the year ended June 30, 2017, operating expenses were $7,265,097 or 1,807% of sales, compared to $3,649,412 or 339% of sales for the year ended June 30, 2016, an increase of $3,615,685 or 99%. Areas in which the Company experienced material changes in operating expenses are discussed below.

For the year ended June 30, 2017, general and administrative expenses were $5,751,464 or 1,431% of sales, compared to $2,142,984 or 199% of sales for the year ended June 30, 2016, an increase of $3,608,480 or 168%. The increase in general and administrative expenses in 2017 was driven by an increase in officer and employee compensation, including approximately $1,439,096 in stock option-related compensation to two new outside Board Directors in the fourth quarter of fiscal year 2017, rent and storage expenses, and expenses related to the startup of the Eagle Spirit Water brand.

For the year ended June 30, 2017, advertising and marketing expenses were $1,513,633 or 377% of sales, compared to $1,340,428 or 125% of sales for the year ended June 30, 2016, an increase of $173,205 or 13%. The increase in advertising and marketing expenses in 2017 was due to increased promotional spending, broker commissions, promotions contractors, and advertising and promotional expenses related to the startup of the Eagle Spirit water brand.

For the year ended June 30, 2016, the Company recorded an impairment expense of $166,000 related to its investment in Dollar Shots Club. This represented a 100% impairment on this investment. There was no impairment recorded during the year ended June 30, 2017.

For the year ended June 30, 2017, interest expense was $1,044,431, compared to $203,496 for the year ended June 30, 2016, an increase of $840,935 or 413%. The increase in interest expense, which includes the amortization of the discount on convertible debt and interest on Series C Preferred Stock, was due to increased debt in 2017.

During the year ended June 30, 2016, the Company recorded debt inducement expense of $3,887,618. In order to induce the holder of certain convertible debt to convert his note, he was issued warrants to purchase 41,454,851 shares of common stock at a reduced price. There was no debt inducement expense in 2017.

During the year ended June 30, 2016, the Company recorded a loss of $945,838 on the extinguishment of debt related to the settlement of convertible debt. There was no extinguishment of debt in 2017.

For the year ended June 30, 2017, the Company recorded a gain of $834,242 on the change in the redemption value of the Series C Preferred stock. The redemption value of the Series C Preferred stock is determined based on a formula in the Company’s amended Articles of Incorporation. There was no change in the redemption value during the year ended June 30, 2016.

For the year ended June 30, 2017, the Company recorded a loss on the change in fair value of derivative liability of $1,951,019 compared to a gain of $11,071,250 for the year ended June 30, 2016. In 2017 the loss resulted from the increase in the price of the Company’s underlying stock, which is used to calculate the fair value of the related derivative liability, over the period from July 1, 2016 to June 30, 2017. The gain in 2016 resulted from a decrease in the price of the Company’s stock during the year ended June 30, 2016 and the related decrease in the derivative liability.

For the years ended June 30, 2017 and 2016, the Company recorded no income tax benefit due to a full valuation allowance provided on deferred tax assets resulting from net operating losses.

Three Months Ended June 30, 2018 Compared to Three Months Ended June 30, 2017

The Company’s sales for the three months ended June 30, 2018 were $72,675 compared to net returns of $36,178 for the three months ended June 30, 2017.

The Company’s net loss for the three months ended June 30, 2018 was $1,377,795 compared to $1,666,238 for the three months ended June 30, 2017.

For the three months ended June 30, 2018 sales were $72,675 compared to net returns of $36,178 for the three months ended June 30, 2017, an increase of $108,853. The sales increase was driven by the incremental sales of our newly launched HEMPd product line-up, increased sales of our high alkaline spring water, partially offset by a decrease in sales of our hemp-infused functional beverages and energy shots as inventory was being sold off. Additionally, in the three months ended June 30, 2017 the Company recorded a return of product from a distributor, which resulted in net sales returns. In the three months ended June 30, 2018 sales consisted of approximately 79% online sales, 18% distributor sales, and 3% direct to retailer sales, compared to approximately 58% online sales, 25% distributor sales, and 17% direct to retailer sales for the three months ended June 30, 2017.

For the three months ended June 30, 2018, cost of sales was $109,224 or 150% of sales, compared to $67,609 or (187%) of sales for the three months ended June 30, 2017, an increase of $41,615 or 61%. Cost of sales as a percentage of sales increased in 2018 as a result of price reductions on our hemp-infused functional beverages and energy shots, costs related to the launch and start-up of our HEMPd product line-up, and the write-downs of hemp-infused beverage and energy shot inventory approaching its “best by” date. For the three months ended June 30, 2017 cost of sales was driven by the write-downs of hemp-infused beverage and energy shot inventory approaching its “best by” date. Cost of sales was positively impacted in 2017 as a result of the return of product from a distributor.

For the three months ended June 30, 2018, operating expenses were $1,121,083 or 1,543% of sales, compared to $2,730,140 or (7,546%) of sales for the three months ended June 30, 2017. Areas in which the Company experienced material changes in operating expenses are discussed below.

For the three months ended June 30, 2018, general and administrative expenses were $909,788 or 1,252% of sales, compared to $2,650,173 or (7,325%) of sales for the three months ended June 30, 2017, a decrease of $1,740,385 or 66%. The decrease in general and administrative expenses in 2018 was primarily driven by decreases in compensation expense to former members of the Board of Directors, legal fees and bad debt expense, partially offset by increased corporate salaries in preparation for the launch of the Company’s new HEMPd product line.

For the three months ended June 30, 2018, advertising and marketing expenses were $211,295 or 291% of sales, compared to

$79,967 or (221%) of sales for the three months ended June 30, 2017, an increase of $131,328 or 164%. The increase in advertising and marketing expenses in 2018 was a result of the launch of the Company’s new HEMPd product line-up, partially offset by management’s decision to decrease advertising and marketing expenditures related to the Company’s hemp-infused beverages and energy shots.

For the three months ended June 30, 2018, interest expense was $365,570, compared to $512,732 for the three months ended June 30, 2017, an decrease of $147,162. The decrease in interest expense, which includes the amortization of the discount on convertible debt, excess of the beneficial conversion feature on certain convertible notes payable, and, in 2017, interest on Series C Preferred Stock, was due to decreased debt levels in 2018.

For the three months ended June 30, 2018, the Company recorded a net gain on extinguishment of debt of $5,362 related to the settlement of convertible debt. There was no gain or loss on extinguishment of debt for the three months ended June 30, 2017.

For the three months ended June 30, 2017, the Company recorded a gain on the change in redemption value of Series C Preferred Stock related to the valuation of these shares. There was no change in redemption value in 2018 as the Series C Preferred Stock was cancelled in October 2017 as part of a legal settlement with the holder.

For the three months ended June 30, 2018, the Company recorded a gain on the change in fair value of derivative liability of $140,045 compared to a gain of $846,179 for the three months ended June 30, 2017. In 2018 the gain resulted from the decrease in the price of the Company’s underlying stock, which is used to calculate the fair value of the related derivative liability, from the beginning of the three-month period to the end of the period. In 2017 the gain resulted from an increase in the risk-free interest rate and the Company’s stock volatility factors that are inputs in the derivative liability calculation.

For the three months ended June 30, 2018 and June 30, 2017, the Company recorded no income tax provision due to a full valuation allowance provided on deferred tax assets resulting from net operating losses.

The Company’s sales for the six months ended June 30, 2018 were $123,584 compared to $81,636 for the six months ended June 30, 2017.

The Company’s net loss for the six months ended June 30, 2018 was $3,709,859 compared to a net loss of $6,135,558 for the six months ended June 30, 2017.

For the six months ended June 30, 2018 sales were $123,584 compared to $81,636 for the six months ended June 30, 2017, an increase of $41,948 or 51%. The sales increase was driven by the incremental sales of our newly launched HEMPd product line-up, increased sales of our high alkaline spring water, partially offset by a decrease in sales of our hemp-infused functional beverages and energy shots as inventory was being sold off. Additionally, in the six months ended June 30, 2017 the Company recorded a return of product from a distributor. In the six months ended June 30, 2018 sales consisted of approximately 78% online sales, 19% distributor sales, and 3% direct to retailer sales, compared to 38% online sales, 57% distributor sales, and 5% direct to retailer sales for the six months ended June 30, 2017.

For the six months ended June 30, 2018, cost of sales was $176,214 or 143% of sales, compared to $124,444 or 152% of sales for the six months ended June 30, 2017, an increase of $51,770 or 42%. Cost of sales as a percentage of sales was lower in 2018 due to the return of product from a distributor in 2017, which was partially offset by 2018 price reductions on our hemp-infused functional beverages and energy shots, costs related to the launch and start-up of our HEMPd product line-up, and the write-downs of hemp-infused beverage and energy shot inventory approaching its “best by” date.

For the six months ended June 30, 2018, operating expenses were $2,271,423 or 1,840% of sales, compared to $4,662,949 or 5,711% of sales for the six months ended June 30, 2017. Areas in which the Company experienced material changes in operating expenses are discussed below.

For the six months ended June 30, 2018, general and administrative expenses were $1,990,306 or 1,610% of sales, compared to $3,898,375 or 4,775% of sales for the six months ended June 30, 2017, a decrease of $1,908,069 or 49%. The decrease in general and administrative expenses in 2018 was primarily driven by decreases in compensation expense to former members of the Board of Directors, legal fees and bad debt expense, partially offset by increased corporate salaries in preparation for the launch of the Company’s new HEMPd product line.

For the six months ended June 30, 2018, advertising and marketing expenses were $281,117 or 228% of sales, compared to

$764,574 or 937% of sales for the six months ended June 30, 2017, a decrease of $483,457 or 63%. The decrease in advertising and marketing expenses in 2018 was a result of management’s decision to decrease advertising and marketing expenditures on the Company’s hemp-infused beverages and energy shots, partially offset by an increase in costs related to the launch of the new HEMPd products. Additionally, in 2017 the Company executed a large marketing contract with a third-party promoter and issued stock to a distributor in exchange for promotional activity.

For the six months ended June 30, 2018, interest expense was $3,182,698, compared to $645,783 for the six months ended June 30, 2017, an increase of $2,536,915. The increase in interest expense, which includes the amortization of the discount on convertible debt, excess of the beneficial conversion feature on certain convertible notes payable, and, in 2017, interest on Series C Preferred Stock, was due to increased debt activity in early 2018, partially offset by decreased debt levels in the fourth quarter of 2018.

For the six months ended June 30, 2018, the Company recorded a net loss on extinguishment of debt of $191,138 related to the settlement of convertible debt. There was no gain or loss on extinguishment of debt for the six months ended June 30, 2017.

For the six months ended June 30, 2017, the Company recorded a gain on the change in redemption value of Series C Preferred Stock related to the valuation of these shares. There was no change in redemption value in 2018 as the Series C Preferred Stock was cancelled in October 2017 as part of a legal settlement with the holder.

For the six months ended June 30, 2018, the Company recorded a gain on the change in fair value of derivative liability of $1,988,030 compared to a loss of $1,618,260 for the six months ended June 30, 2017. In 2018 the gain resulted from the decrease in the price of the Company’s underlying stock, which is used to calculate the fair value of the related derivative liability, from the beginning of the six-month period to the end of the period. In 2017 the loss resulted from an increase in the risk-free interest rate and the Company’s stock volatility factors that are inputs in the derivative liability calculation.

For the six months ended June 30, 2018 and June 30, 2017, the Company recorded no income tax provision due to a full valuation allowance provided on deferred tax assets resulting from net operating losses.

Known Trends and Uncertainties Expected to Have a Material Impact on Revenues

We expect our revenues to increase materially during the second half of 2018, primarily due to anticipated sales under our private label manufacturing contract with CBD Alimentos SA de CV (“CBD Alimentos”). Although the initial order from CBD Alimentos was expected during the second quarter of 2018, we now expect to receive the initial order and ship the initial product late in the third quarter or early in the fourth quarter of 2018, with additional orders to follow. In addition, we expect to generate additional revenue from our newly-acquired FitWhey business unit, which will continue to sell the FitWhey protein drink. Finally, we expect revenue growth from our new HEMPd branded CBD-infused flavored and unflavored waters and other HEMPd branded products. Revenue from the new FitWhey and HEMPd products is inherently difficult to project, and will depend on the level of market acceptance and market penetration that can be achieved for these new products.

As of June 30, 2018, the Company had current assets of $980,347, consisting of cash of $325,158, accounts receivable (net) of $21,517, inventory of $77,390, and prepaid expenses and other current assets of $556,282. As of June 30, 2018,the Companyhad current liabilities of $2,183,131, consisting of accounts payable and accrued liabilities of $406,113, convertible notes payable (net) of $1,083,397, notes payable of $43,808, accrued interest of $50,389, and derivative liability of $599,424. During the six months ended June 30, 2018, the Company received proceeds of $2,514,562 related to the sale of 244,217,685 shares of common stock under its Equity Financing Agreement with GHS Investments, LLC.

Net cash used in operating activities during the six months ended June 30, 2018 was $2,285,142 compared to $1,112,988 during the six months ended June 30, 2017. The change was principally driven by management’s greater use of stock-based payments to vendors and employees in 2017 compared to 2018 as well as payments on accounts payable and accrued liabilities.

Net cash used in investing activities during the six months ended June 30, 2018 was $42,185 compared to $13,461 during the six months ended June 30, 2017. The primary reason for the increase is the Company’s investment in software development for its new HEMPd.com website.

Net cash provided by financing activities during the six months ended June 30, 2018 was $2,635,502 compared to $1,063,063 during the six months ended June 30, 2017. In 2018, proceeds of $300,000 were from the issuance of convertible notes payable compared to $370,000 in 2017. In 2017 the Company also received proceeds of $189,000 from the issuance of related party convertible notes payable. There were no proceeds from the issuance of related party convertible notes payable in 2018. In 2018 the Company repaid $172,932 on convertible and related party convertible notes payable. There were no repayments in 2017. In 2017 the Company repaid $25,000 on its related party convertible notes payable. In 2018 there were proceeds of $2,514,562 from the issuance of common stock compared to $534,700 in 2017.

Recently, the Company’s operations have been funded primarily through the private sales of common stock or the issuance of convertible promissory notes, which are convertible to common stock at fixed prices ranging from $0.005 to $0.01 or at discounts to market price of 50%. As of June 30, 2018 the Company had total notes payable outstanding of $1,127,205 (net of discount).

On October 12, 2017 the Company executed an Equity Financing Agreement (“EFA”) with GHS Investments LLC (“GHS”). Under the agreement, GHS has committed to purchase up $12 million of the Company’s common stock over a 24-month period at a 20% discount off the market price, as defined in the agreement. The agreement contains certain restrictions on the timing of the stock purchases and required the Company to file a registration statement with the Securities and Exchange Commission (“SEC”) to register the common shares issuable under the agreement. On November 1, 2017, the Company filed a Registration Statement on Form S-1 to register 300,000,000 common shares to be resold by GHS. On February 9, 2018 the Company received a Notice of Effectiveness from the SEC on an amended Form S-1 registering 250,000,000 common shares. The Company began stock sales to GHS on February 13, 2018 and has since sold all 250,000,000 shares to GHS.

During the next twelve months we expect our operational cash shortfall to be approximately $850,000 to $1,500,000, depending on the timing, development, advertising, and marketing needs related to our future product rollouts. Our cash needs will be higher in the second quarter of 2018, we expect our outside cash needs to lessen with a net operational positive cash flow in the fourth quarter of 2018. We expect our operational cash needs will be met by our current funding arrangements with GHS.

The Company expects the SPA with GHS to cover the operational shortfall over the next twelve months. In the event that the SPA does not provide adequate funding, either for contractual, market, or other reasons, the Company would seek funding from other financing sources as it has done in the past. There are no guarantees the Company would be able to source such incremental funding. In this case, the Company would have to curtail its expansion plans.

Below is a summary of the potential total proceeds to be received under the SPA under a range of trading prices, including our ~~$0.0119 September~~$0.01276 October 4, 2018 closing price and prices which are 30% greater and lesser than such price in order to reflect a range of possibilities depending on the price fluctuations which are typical of our common stock:

	@ 82% of Close		@ 82% of Close (+30%)		@82% of Close (-30%)		@ 82% of Close		@ 82% of Close (+30%)		@82% of Close (-30%)
Closing Stock Price – August 6, 2018	$	.0119	$	.0119	$	.0119
Closing Stock Price – October 4, 2018							$	.01276	$	.01276	$	.01276
As Adjusted for Discount	$	.00952	$	.01238	$	.00666	$	.01021	$	.01327	$	.00715
Registered Shares		320,000,000		320,000,000		320,000,000		320,000,000		320,000,000		320,000,000
Total Proceeds	$	3,046,400	$	3,960,320	$	2,132,480	$	3,266,560	$	4,246,528	$	2,286,592

The Company has a shareholders’ deficit of $985,464 and an accumulated deficit of $33,994,478 as of March 31, 2018 and has generated operating losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue raising capital.

In December 2001, the SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. We do not believe that the following accounting policies currently fit this definition:

The preparation of the financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Certain of the Company’s estimates could be affected by external conditions, including those unique to its industry, and general economic conditions. It is possible that these external factors could have an effect on the Company’s estimates that could cause actual results to differ from its estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and record adjustments when necessary.

The Company follows the guidance of the Accounting Standards Codification (“ASC”) Topic 605, “Revenue Recognition.” It records revenue from the sale of its products when persuasive evidence of an arrangement exists, product delivery has occurred, the selling price to the customer is fixed or determinable and collectability of the revenue is reasonably assured. The Company has not experienced any significant returns from customers and accordingly, in management’s opinion, no reserve for returns has been provided. Payments received prior to shipment of goods are recorded as deferred revenue.

The Company has a policy of reserving for uncollectible accounts based on the best estimate of the amount of probable credit losses in our existing accounts receivable. We extend credit to customers based on an evaluation of their financial condition and other factors. The Company generally does not require collateral or other security to support accounts receivable and perform ongoing credit evaluations of customers and maintain an allowance for potential bad debts if required.

It is determined whether an allowance for doubtful accounts is required by evaluating specific accounts where information indicates the customers may have an inability to meet financial obligations. In these cases,weuse assumptions and judgment, based on the best available facts and circumstances, to record a specific allowance for those customers against amounts due to reduce the receivable to the amount expected to be collected. These specific allowances are re-evaluated and adjusted as additional information is received. The amounts calculated are analyzed to determine the total amount of the allowance. The Company may also record a general allowance as necessary.

Direct write-offs are taken in the period when we have exhausted our efforts to collect overdue and unpaid receivables or otherwise evaluate other circumstances that indicate the collectability of receivables.

Inventories, which consist of the Company’s product held for resale, are stated at the lower of cost, determined using the first-in, first-out, and net realizable value. Net realizable value is the estimated selling price, in the ordinary course of business, less estimated costs to complete and dispose of the product.

If the Company identifies excess, obsolete or unsalable items, its inventories are written down to their realizable value in the period in which the impairment is first identified. Shipping and handling costs incurred for inventory purchases and product shipments are recorded in cost of sales in the Company's statements of operations.

The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.

The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of our short and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

The derivative liability, which relates to the conversion feature of convertible debt and common stock warrants and options, is classified as a Level 3 liability, and is the only financial liability measure at fair value on a recurring basis.

The estimated fair value of the derivative instruments were valued using the Black-Scholes option pricing model, using the following assumptions as of December 31, 2017, June 30, 2017, and June 30, 2016:

Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets. Expenditures for additions and improvements are capitalized; repairs and maintenance are expensed as incurred.

The Company evaluates intangible assets for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flow and recognizes an impairment loss when the estimated undiscounted future cash flow expected to result from the use of the asset plus the net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. When the Company identifies an impairment, it reduces the carrying amount of the asset to its estimated fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values. During the six months ended December 31, 2017 the Company recorded an impairment charge on the goodwill related to the acquisition of Rocky Mountain High Water Company in the amount of $59,163. As of December 31, 2017 the goodwill related to this acquisition is fully impaired. No impairment charges were recorded during the year ended June 30, 2017 or the six months ended December 31, 2016. During the year ended June 30, 2016 the Company recorded an impairment of $166,000 on its investment in Dollar Shots Club when it was determined that the Company would not likely recover its investment. The $166,000 represented the entire investment.

Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values, in accordance with FASB ASC Topic 718. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

The Company issued restricted stock to consultants and employees for various services. Cost for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The value of the common stock is to be measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities.” Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as freestanding derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classify our preferred shares in shareholders’ equity. Our preferred shares do not feature any redemption rights within the holders’ control or conditional redemption features not within our control. Accordingly, unless otherwise noted, all issuances of preferred stock are presented as a component of consolidated shareholders’ equity (deficit).

Unless otherwise noted, we have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(1) of the JOBS Act. This allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of our election, our financial statements may not be comparable with other public companies.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09,Revenue from Contracts with Customers, which will replace most existing revenue recognition guidance in U.S. GAAP and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures about the nature, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. ASU 2014-09 allows for adoption either on a full retrospective basis to each prior reporting period presented or on a modified retrospective basis with the cumulative effect of initially applying the new guidance recognized at the date of initial application, which will be effective for the Company beginning January 1, 2019. The Company is currently evaluating the impact of ASU 2014-09, including the transition method, on its consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02,Leases, which requires lessees to recognize on the balance sheet a right-of-use asset, representing their right to use the underlying asset for the lease term, and a lease liability for all leases with terms greater than 12 months. The guidance also requires qualitative and quantitative disclosures designed to assess the amount, timing and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for the Company beginning January 1, 2020. The Company is currently evaluating the impact that ASU 2016-02 will have on its consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13,Financial Instruments-Measurement of Credit Losses on Financial Instruments, which requires measurement and recognition of expected credit losses for financial assets held. ASU 2016-13 is effective for the Company beginning January 1, 2021 and the Company is currently evaluating the impact that ASU 2016-13 will have on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-01,Business Combinations: Clarifying the Definition of a Business, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. ASU 2017-01 is required to be applied prospectively and will be effective for the Company beginning January 1, 2019. The impact on our consolidated financial statements will depend on the facts and circumstances of any specific future transactions.

The Company recently updated and began execution of its long-term strategic plan. Management’s goal is to become the cutting-edge leader in CBD and hemp-infused food, beverage and other health conscious product categories. This includes the use of hemp and CBD in products under the HEMPd brand name. In late 2017, the Company executed its first private label manufacturing agreement. Production on an initial purchase order is planned to start in the second quarter of 2018.

The Company’s Wellness For Life, Inc. subsidiary currently markets the following lineup of CBD-infused products under the HEMPd brand:

Under its Rocky Mountain High Brands name, the Company currently markets one hemp-infused 16 oz. beverage including:

Naturally Flavored Citrus Energy Drink - A citrus energy drink that contains 100mg of hempseed extract and is complemented with ginseng and guarana extract, caffeine and other ingredients

The Company is selling its remaining inventory of the drink. In order to execute this plan, the Company is offering larger discounts to distributors, retailers, and consumers and higher commissions to its broker network. This has resulted in lower gross margins and write-downs of inventory to net realizable value.

Our Eagle Spirit Land and Water Company currently markets its naturally high alkaline spring water in three sizes: 1 liter and 16.9 oz. plastic bottles sold in cases of 12 and 24, respectively, and a 2.64-gallon (10-liter) Bag in a Box.

In December 2017, the Company executed a three-year Master Manufacturing Agreement with CBD Alimentos SA de CV (“CBD-Alimentos”), a Mexican food and beverage distributor. Under the agreement (as amended), CBD Alimentos will be our exclusive distributor in Mexico of all of our energy and soft drinks with CBD. In turn, we will be CBD Alimentos’ exclusive supplier of such products. For the exclusivity to remain effective through 2018, we must supply, and CBD Alimentos must purchase, at least 16,000,000 cans. Volume requirements for 2019 will be negotiated. The beverages supplied to CBD Alimentos will be private label products made to order for CBD Alimentos, and we will cooperate on laboratory and taste-testing of each batch of beverages at the co-packing facility. CBD’s initial purchase order will be at least 8,000,000 cans, with a 50% deposit on all orders to be segregated into a separate operating account established and maintained by the Company. CBD Alimentos will maintain a positive cash balance in the account at all times. The Company will have full unilateral authority to disburse funds from the account to vendors, suppliers, co-packers and the Company solely for the purposes of production and the Company’s margin on the sale.

On July 25, 2018, we acquired the assets of BFIT Brands, LLC, an Arizona company that markets and distributes FitWhey, a water-based protein drink combined with caffeine and a vitamin B pack. Following the acquisition, we will continue to sell the FitWhey brand protein drink. Our plans to increase sales and distribution of this product are under development.

The Company is currently developing HEMPd branded CBD-infused flavored and unflavored waters. Management expects these CBD-infused waters to be launched in July 2018. Other HEMPd products are currently in the development stage and are expected to be marketed later in 2018 and early 2019.

Historically, the Company has depended on a network of brokers and distributors to represent its product in the market. During its first year of operation, the Company signed twenty-four distributors across the country. For the six months ended December 31, 2017, the Company’s two largest distributors each accounted for 6% of sales.

Initially, the Company’s HEMPd products are being sold primarily direct-to-consumer via the internet through Amazon and eBay and our proprietary website www.HEMPd.com, with retail and distributor channels gradually building during 2018. The direct-to-consumer channel is generally more profitable than the other channels. The Company also maintains its www.LiveRockyMountainHigh.com and www.EagleSpiritWater.com websites, including e-commerce capabilities.

In May 2016, the Company executed a one-year agreement with MBA Beverage to coordinate the manufacturing of our hemp-infused beverage products. MBA Beverage acted as our outsourced supply-chain management and coordinated every aspect of the manufacturing process. The contract expired in May 2017 and was not renewed.

Through early 2018, Blues City Brewery, LLC (“Blues City”) in Memphis, Tennessee, a subsidiary of City Brewing Company, LLC, completed all beverage production and canning. Blues City is an FDA registered facility that is audited annually to ensure compliance with FDA GMP (Good Manufacturing Practices) for food safety. MBA Beverage schedules beverage production with Blues City. Upon completion of the production, the Company stored finished product at Blues City, awaiting sale. The Company did not contract with Blues City directly.

NutraGenecs TechniChef (“NutraGenecs”) of Meridian, Texas collaborates with the Company for product formulation under a formal agreement. All formulas developed by NutraGenecs are the property of the Company.

Our naturally high alkaline spring water is cold-filtered and packaged by a third-party water processor, Water Event Pure Water Solutions (“Water Event”).

On February 24, 2018 the Company executed an Amazon Brand Development and Launch Agreement with BuyDMi, Inc. (DBA GoodforYou.com) for the new HEMPd product line. Under this contract GoodforYou.com is creating an Amazon page for the initial 17 HEMPd products, converting all HEMPd products to Amazon Prime offerings, providing customer phone and email support, managing inventory forecasting, shipping, storage, and returns, and launching sponsored ad campaigns.

On March 20, 2018 the Company executed a Fulfillment and Customer Support Services Agreement with GoodforYou.com for the new HEMPd product line. Under this contract GoodforYou.com is managing inventory and providing storage, shipping, and customer support services.

We are subject to numerous federal, state, local, and foreign laws and regulations, including those relating to:

The Company’s hemp and CBD products are derived from industrial hemp, not marijuana. There is a clear scientific distinction between the two plants: The Company’s products contain less than 0.3% tetrahydrocannabinol (“THC”), the psychoactive compound found in marijuana. (Most marijuana contains over 10% THC). There is also a clear legal distinction between the two plants. While marijuana is illegal under U.S. federal law, the industrial hemp used in our products is 100% legal at the federal level. It is grown under a duly-licensed state agricultural pilot program conducted by the Colorado Department of Agriculture, as authorized by the 2014 U.S. Farm Bill. The Farm Bill explicitly exempts hemp products from the definition of “marijuana” and explicitly exempts hemp products from the purview and regulation of the Controlled Substances Act. Furthermore, the 2016 Omnibus Appropriations Act specifically instructs federal agencies not to interfere with the transport or sale of pilot program hemp products such as the ones sold by the Company.

Our beverage products are not subject to direct FDA approval as the FDA does not perform review testing or approval of food, beverages or dietary supplements. The FDA requires that we manufacture our products in commercial manufacturing facilities that are annually audited to ensure that they pass inspection based on Good Manufacturing Practices for food safety.

The Company currently has five officers and three non-officer employees. The Company uses independent contractors, when necessary, to support operational or back-office functions.

As a company with less than $1 billion in revenue in our last fiscal year, we are defined as an “emerging growth company” under the Jumpstart Our Business Startups (“JOBS”) Act. We will retain “emerging growth company” status until the earliest of:

The last day of the fiscal year following the fifth anniversary of our first sale of common stock pursuant to a registration statement filed under the Securities Act of 1933, as amended, whichwe refer to in this document as the Securities Act;

The date on whichwequalify as a large accelerated filer under Rule 12b-2 adopted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (i.e., an issuer with a public float of $700 million that has been filing reports with the U.S. Securities and Exchange Commission (“SEC”) under the Exchange Act for at least 12 months).

As an emerging growth company,wemay take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to SEC reporting companies. For so long asweremain an emerging growth companywewill not be required to:

Have an auditor report on our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Wall Street Reform and Consumer Protection Act of 2002;

Comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);

Disclose certain executive compensation related items, aswewill be subject to the scaled disclosure requirements of a smaller reporting company with respect to executive compensation disclosure; and

Present more thantwoyears of audited financial statements andtwoyears of selected financial data in a registration statement for our initial public offering of our securities.

Pursuant to Section 107(b) of the JOBS Act, we have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(2) of The JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result, our financial statements may not be comparable to companies that comply with public company effective dates. Section 107 of the JOBS Act provides that our decision to opt into the extended transition period for complying with new or revised accounting standards is irrevocable.

Because the worldwide market value of our common stock held by non-affiliates, or public float, is below $75 million,weare also a “smaller reporting company” as defined under the Exchange Act. Some of the foregoing reduced disclosure and other requirements are also available to us becauseweare a smaller reporting company and may continue to be available to us even afterweare no longer an emerging growth company under the JOBS Act but remain a smaller reporting company under the Exchange Act. As a smaller reporting companyweare not required to:

At present, we do not own any real property. As of December 31, 2017, we leased approximately 7,000 square feet of office space at 9101 LBJ Freeway, Suite 200, Dallas, Texas 75243. Our lease period began on September 1, 2016 and terminates on August 31, 2019. Payments under the lease are as follows:

In connection with this lease, we also purchased used office furniture from the landlord and financed this purchase with a note payable in the amount of $40,122 with an interest rate of 0% and monthly payments of $1,114 over thirty-six monthly installments. As of June 18, 2018, the balance of this note was $16,067.

On January 18, 2018, the RMHC entered into a 12-month office use agreement for office space in Denver, Colorado. Monthly payments are $91.

Water Event, Carrollton, Texas –wecurrently lease space for both hemp-infused beverages and spring water. The Company also stores small quantities of ice barrels and other packaging at this location.

Our monthly rent varies depending on how much inventory is stored. Inventory levels fluctuate based on production and sales.

The Company is currently evaluating its growth requirements and researching alternatives to lower its recurring expenses for warehouse space.

Rocky Mountain High Brands, Inc. v Lyonpride Music, LLC, United States District Court Northern District of Texas, 3:18-cv-00045-C

The Company filed suit against Lyonpride Music, LLC (“Lyonpride”) for fraud and for declaratory relief with respect to a contract between the parties. The Company is seeking monetary damages against Lyonpride. The case has been referred to binding arbitration.

Los Angeles Superior Court, BC669367, filed July 24, 2017. Statewide Beverage Company, Inc. v. Rocky Mountain High Brands, Inc.

Statewide Beverage Company, Inc. (“Statewide”) filed a breach of contract claim, and the Company has filed counterclaims for breach of contract, common law fraud and declaratory relief. The parties have executed a binding agreement to settle this matter. Under the agreement, the Company will not be required to pay damages to Statewide and will cancel 1,818,180 shares of common stock previously issued to affiliates of Statewide.

Dallas County Texas, Case Number DC-17-15441 filed November 8, 2017. Rocky Mountain High Brands, Inc. f/k/a Republic of Texas Brands, Inc. Plaintiff, vs. Jerry Grisaffi, Joe Radcliffe, LSW Holdings, LLC, Lily Li, Epic Group One, LLC, Kenneth Radcliffe, Dennis Radcliffe, Phil Uhrik, Michael Radcliffe, Frank Izzo, Morgan Albright, John Garrison, BB Winks, LLC, Crackerjack Classic, LLC, and Universal Consulting, LLC.

The Company is seeking the return of Series A Preferred Stock (“Series A”) issued to Jerry Grisaffi (“Grisaffi”), RMHB’s former Chairman of the Board, and common stock issued to certain other defendants or later obtained by certain other defendants for little or no consideration paid to the Company. The Company alleges, among other things, that Grisaffi breached his fiduciary duty to the Company by issuing these Series A shares to himself and common stock to himself and others. RMHB is also seeking to void the Indemnification and Release Agreement (“Indemnification”) between the Company and Grisaffi that was executed in June 2017.

Grisaffi filed a counterclaim against the Company seeking payment for two promissory notes allegedly owed to him, as well as relief under the Indemnification. Those notes have been accounted for in the Company’s consolidated financial statements. Those counterclaim matters have been proactively addressed in the Company’s original suit, seeking to void the Indemnification and the two notes based on, among other things, fraud of Grisaffi. Grisaffi has also filed a derivative suit within the main lawsuit. The Company has filed a motion to dismiss the derivative suit and is awaiting a ruling on that motion.

In June 2018 LSW and Li filed counterclaims against the Company, generally seeking an increase of voting rights of the Series A shares to 1200:1, a declaration that the Series A shares were validly issued to Grisaffi, challenging the authorized share increase of the Company, claiming securities fraud by the Company with respect to the Series A Shares purchased from Grisaffi and other common stock allegedly purchased by LSW and Li, as well as fraud, breach of contract and negligent misrepresentation by the Company. LSW seeks $10,000,000 in damages from the Company, for the $3,500,000 which was paid to Grisaffi for said Series A shares and for which LSW claims to somehow be the responsibility of the Company to cover, and the remaining $6,500,000 for money allegedly spent by LSW in “developing a distribution system in China” and other alleged “investments” of Li and LSW in the Company. LSW and Li also seek exemplary damages. The Company intends to vigorously defend these counterclaims.

On August 30, 2018, the Trial Court entered a final judgment and order in our favor and against Grisaffi. On August 29, 2018, after a show cause hearing, the Trial Court entered an order sanctioning Grisaffi for his repeated and unexcused refusals to make discovery in the case. As a sanction, the Trial Court struck Grisaffi’s pleadings in the case and, on August 30, 2018, entered a Default Judgment against him. Under the Trial Court’s Default Judgment:

1. The Court entered a monetary judgment against Grisaffi and in favor of the Company in the amount of $3,500,000 for fraud, breach of fiduciary duty, and conversion with respect to the Series A preferred stock.

2. The Court declared that the Employment Agreement with Grisaffi dated April 1, 2013 was voidab initio and unenforceable, and that all stock and promissory notes issued in connection with the Employment Agreement were also voidab initio and of no force and effect, including but not limited to:

3. The Court declared that Grisaffi’s sale of the Series A Preferred Stock to LSW Holdings, LLC was made with actual intent to hinder, delay, or defraud creditors and was thus a fraudulent transfer under Texas law.

4. The Court declared that the issuance of 10,000,000 shares of common stock to Lily Li and the 11,000,000 shares of common stock issued to Epic One Group, LLC were made without lawful consideration, and constituted breaches of fiduciary duty by Grisaffi.

5. The Court declared that an Indemnification was procured through fraud and breach of fiduciary duty and is therefore void and unenforceable.

6. The Court ruled that Grisaffi shall take nothing by his counterclaims in the case.

Finally, the Court ruled that our continuing claims against the other defendants in the case are to be severed and docketed under a separate cause of action and case number. The judgment and order entered August 30, 2018 concludes our litigation in district court as against Grisaffi. On September 4, 2018, Mr. Grisaffi filed a Notice of Appeal in the case against him. We will continue to pursue our claims against the other defendants in the case.

The following table sets forth, as of August 8, 2018, the name, age and positions of our executive officers and directors.

The business background and certain other information about our directors and executive officers is set forth below:

Michael Welch joined the Company in January 2016 as Chief Financial Officer. He was appointed President and Chief Executive Officer in February 2016. In September 2017 Mr. Welch was appointed Chairman of the Board of Directors.

Mr. Welch brings more than thirty years of executive and financial management experience to the Rocky Mountain High Brands team. Prior to joining RMHB, Mr. Welch served as CFO Managing Partner for Aventine Hill Partners, a professional services firm from July 2014 to December 2015. Mr. Welch served as Chief Financial Officer and Consultant for multiple small cap companies in Dallas, Texas from June 2011 to June 2014. Mr. Welch was the Chief Financial Officer and one of the founders of Stephan Pyles Concepts, a Dallas-based, privately-held restaurant holding company from February 2005 to May 2011.

In the late 90’s, Mr. Welch was part of the founders group of Resources Global Professionals (RGP), a publicly-traded, international consulting firm that was initially owned by Deloitte. Prior to his involvement with RGP, for more than ten years Mr. Welch was employed by Landmark Land Company, a publicly traded multi-state real estate developer and operator of golf and tennis resorts and hotels, commercial and residential real estate, life insurance, mortgage and savings and loans. His positions included Chief Operating Officer, Vice President of Management Systems, and Controller. Mr. Welch also served as Chief Financial Officer of Oak Tree Savings Bank, a subsidiary of Landmark Land Company and a statewide savings and loan based in New Orleans, LA.

Mr. Welch is an alumnus of the audit staff at Deloitte and joined the firm immediately after earning a Bachelor of Business Administration from the University of Oklahoma. Mr. Welch is a Louisiana CPA (inactive status) and has recently completed a term on a not-for-profit board. Mr. Welch currently serves on an Advisory Board for a privately held services company with which he directed a management-led buyout from the founder of the company.

Mr. Mielke has over 28 years’ experience in accounting and finance leadership positions. Prior to joining RMHB, Mr. Mielke was National Partner, Technical Accounting for Aventine Hill Partners, a Texas-based professional services firm. He founded and led that firm’s Technical Accounting Group where he provided technical accounting and finance services to public and private clients. Prior to Aventine Hill, Mr. Mielke was Chief Financial Officer for a high-growth, publicly-traded retailer, but spent the majority of his career at Deloitte where he was audit partner in the firm’s Dallas office. He also previously served as senior financial analyst at PepsiCo’s corporate headquarters in Purchase, NY. His experience includes working with public and private companies in strategic management, accounting, financial reporting, Sarbanes-Oxley compliance, investor relations, initial and secondary public offerings, mergers, acquisitions and divestitures, process improvement and systems implementations.

Mr. Mielke received his Master and Bachelor of Business Administration degrees from Southern Methodist University. He has been a Certified Public Accountant in the State of Texas since 1991. He serves on the Board of Directors of the Dallas Chapter of Financial Executives International.

David Seeberger joined the Company in March 2016 as Vice President, Legal. In September 2017 Mr. Seeberger was appointed to the Board of Directors.

Mr. Seeberger received his B.A. from Grinnell College in Grinnell, Iowa and earned his J.D. from the University of Toledo - College of Law in Toledo, Ohio. Mr. Seeberger is admitted to practice before the Supreme Court of Texas and the United States District Courts for the Northern and Eastern Districts of Texas. He has also practiced in other State and Federal Courts on a pro hoc basis. Mr. Seeberger is also admitted to practice before the Securities and Exchange Commission (SEC).

Mr. Seeberger’s legal experience spans in excess of twenty-five years of professional practice within the Dallas, Texas area. Mr. Seeberger has been privileged to associate with and has been a partner in various small law firms throughout his legal career – for the past decade, Mr. Seeberger has been in private practice, and maintains membership in the State Bar of Texas and the Dallas Bar Association.

Mr. Seeberger’s career has included all areas of corporate and small business - due diligence, corporate and business litigation as well as the areas associated therewith, including general legal counsel for corporate, real estate and commercial bankruptcy proceedings and corporate turnaround efforts. Mr. Seeberger is an AV Preeminent rated attorney resulting from the AV Preeminent-Peer Review Rating as conducted by Martindale-Hubbell. Mr. Seeberger has been engaged, contracted with, or employed by RMHB since 2012.

CHARLES SMITH – DIRECTOR, CHIEF OPERATING OFFICER, AND PRESIDENT OF EAGLE SPIRIT LAND AND WATER COMPANY

Charles (Chuck) Smith joined the Company in February 2016 as a Director and Chief Operating Officer. In November 2016, Mr. Smith was also appointed President of Eagle Spirit Land & Water Company.

Within the last six years, Mr. Smith has served in several key strategic roles entailing a wide-range of corporate governance. During the time period from 2007 to 2014, Mr. Smith served as a Managing Partner and Managing Member of San Carlos Associates, a multi-million-dollar investment entity located in Dallas, Texas. In addition, until the properties recently sold in 2011, Mr. Smith served as a former Managing Partner and Managing member to several investment partnerships in Midland and El Paso, Texas, with indicated values that exceed $30 million. These properties included Cornerstone Village and Villa De Madison. Similarly, Mr. Smith currently retains a partnership interest and maintains a consulting relationship at Sawyers Mill in Arlington, Texas – an entity that he has maintained a relationship with since the early 1990’s.

Mr. Smith graduated with honors from University of Texas at Dallas with a Bachelor's Degree in Economics and Finance. He has been an active participant in real estate investment opportunities for almost 35 years.

John Blackington joined the Company in February 2018 as Chief Commercialization Officer. In 2001, Mr. Blackington formed one of the leading beverage/food consulting groups in the U.S., GBS Growth Partners. As Managing Partner of GBS, he led the development of cutting-edge commercialization strategies for many successful companies, including Bolthouse Farms, Celsius, Soylent, and BYB Brands, now owned by Coca-Cola. GBS strategies are known for their focus on consumers and building loyal daily brand users.

Mr. Blackington has jump-started a number of successful new brands in critical areas ranging from building sales and distribution systems, expanding retail availability, developing equity strategies, and strategic partnerships and acquisitions. He created the “Smart Equity Project”, an initiative of linking early stage companies with major industry players, bringing critical growth resources to promising brands, and needed growth diversification to large companies.

Mr. Blackington received his BS and MBA from the Wharton School of Business at the University of Pennsylvania.

Mr. Morrison is Principal Broker and Owner of Win Morrison Realty. Mr. Morrison spent many years as an IBM executive, based in the former IBM Kingston facility. He operated his own retail business for a time (the Snowflake Ski Shop), and also worked as an antique dealer for most of his adult life. Mr. Morrison opened the Kingston office of Win Morrison Realty in 1982. Win Morrison Realty now has five offices to serve the region. Currently, the company is actively pursuing expansion into other locations within other parts of the region.

Mr. Blythe is the Founder and Managing Partner of TDF Resources, an advisory and investment firm he founded in January 2009 that provides advisory, management, and transaction services to public and private companies across a wide spectrum of industries. Mr. Blythe served on the Board of Directors of Journal Communications, Inc., an NYSE-listed company, from 2013 until its sale in 2015. Mr. Blythe served on the Board of Directors of Total Outdoor Corp. from 2011 to 2013 and served as its Co-President and Chief Financial Officer from 2012 to 2013. From 2001 to 2009, Mr. Blythe was with Harte-Hanks, Inc., a NYSE-listed direct and targeted marketing services company. He served in various roles at Harte-Hanks, including as a member of the Board of Directors, President and Chief Executive Officer, Executive Vice President and Chief Financial Officer, Secretary, and Vice President – Legal. Prior to joining Harte-Hanks, Mr. Blythe served as Senior Vice President – Corporate Development & General Counsel of Hearst-Argyle Television, Inc., a NYSE-listed company, and its predecessor, Argyle Television, Inc. Mr. Blythe previously served on the Boards of Directors of Argyle Security, Inc., where he chaired its Audit Committee, and New Vision Television, Inc.

Mr. Blythe holds a Juris Doctor degree from Duke University and a Bachelor of Science degree from Miami University in Oxford, Ohio.

Our directors are appointed for a one-year term to hold office until the next annual general meeting of our shareholders or until removed from office in accordance with our bylaws. Officers are appointed by our Board of Directors and hold office until they are removed by the Board, their contract expires, or they resign.

There are no family relationships between or among the directors, executive officers or persons nominated or chosen by us to become directors or executive officers.

To the best of our knowledge, during the past ten years, none of the following occurred with respect to a present or former director, executive officer, or employee: (1) any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or withintwoyears prior to that time other than the Chapter 11 bankruptcy proceeding of the Company in 2013 - 2014; (2) any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses); (3) being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities; and (4) being found by a court of competent jurisdiction (in a civil action), the SEC or the Commodities Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated.

On December 16, 2013 the Company filed a Chapter 11 bankruptcy petition in the United States Bankruptcy Court for the Northern District of Texas, Dallas Division, Case Number 13-36434-bjh-11. In early 2013, the Company sought to acquire a barbeque company and sought to raise capital and entered into an agreement with Empire Capital LLC (“Empire”) to assist in the raising of capital for the acquisition. By late 2013, the acquisition had fallen through due to the inability to obtain the needed financing. Empire then sued the Company claiming it was owed approximately $200,000 for its services on behalf of the Company along with additional damages. The Company disputed the claims and filed the Chapter 11 bankruptcy to restructure its current indebtedness and to provide a framework for moving forward. On May 22, 2014 the Company filed its Disclosure Statement and Plan of Reorganization, and on July 2, 2014 a hearing was held and the Plan of Reorganization was confirmed by written order of the Bankruptcy Court dated July 11, 2014.

The material terms of the Order Confirming Debtor’s Plan of Reorganization (the “Bankruptcy Order”) are contained within the Amended Plan of Reorganization (the “Plan”). The Plan was a consensual plan, in that a majority of all creditors in all classes and the equity holders voting voted to accept the Plan. The fundamental material terms of the Plan relate to the allowance or disallowance of claims and treatment of allowed claims and classes of claims, and then to the means for execution of the Plan.

The Plan created five classes of creditors. The Plan contained a separate and distinct obligation of the Company for each of the classes of creditors. The treatment of the Company’s obligation for each class was set forth in Article 5 of the Plan. The Class 1 Claimants consisted of allowed administrative claims and were to be paid in full on the effective date of the Plan. The only Class 1 Claimant was the Debtor’s attorney,whowas paid in full after Court approval of his fee application. Class 2 Claimants consisted of allowed non-insider general unsecured claims. Those Class 2 Claimants were to be paid in full on their claims by receiving 5% of their allowed claim on the effective date of the Plan, and the remainder in 60 equal monthly payments. The Class 3 Claimants consisted of allowed insider general unsecured claims. The Class 3 Claimants consisted of three claimants and their claims were resolved by the issuance of stock of the Debtor. Class 4 Claimants consisted of the allowed claims of the Empire Group, as defined in Class 4. The Class 4 Claimants consisted of four claimants and their claims were resolved by the settlement of pending bankruptcy and non-bankruptcy litigation and other matters with the Class 4 Claimants, which included the return of shares of Debtor’s stock to treasury by one claimant of that Class and the issuance of other shares and delivery of a payment of $50,000.00 to another claimant of that Class. Class 5 Claimants consisted of allowed equity interest holders, and those claimants retained their shares of stock in the Debtor.

The means for execution of the Plan are set forth in Article 6 of the Plan, which contains the matters to be addressed by the Company, primarily those dealing with the obligations to the classes of creditors.

Until further determination by the Board, the full Board of Directors will undertake the duties of the Audit Committee, Compensation Committee, and Nominating Committee.

We do not have a separately designated standing audit committee. The entire Board of Directors performs the functions of an audit committee, but no written charter governs the actions of the Board when performing the functions of what would generally be performed by an audit committee. The Board approves the selection of our independent accountants and meets and interacts with the independent accountants to discuss issues related to financial reporting. In addition, the Board reviews the scope and results of the audit with the independent accountants, reviews with management and the independent accountants our annual operating results, considers the adequacy of our internal accounting procedures and considers other auditing and accounting matters including fees to be paid to the independent auditor and the performance of the independent auditor.

Our Board of Directors does not maintain a nominating committee. As a result, no written charter governs the director nomination process. Our size and the size of our Board, at this time, do not require a separate nominating committee.

When evaluating director nominees, our directors consider the following factors:

The knowledge, skills and experience of nominees, including experience in finance, administration or public service, in light of prevailing business conditions and the knowledge, skills and experience already possessed by other members of the Board;

Our goal is to assemble a Board that brings together a variety of perspectives and skills derived from high quality business and professional experience. In doing so, the Board will also consider candidates with appropriate non-business backgrounds.

Other than the foregoing, there are no statedminimumcriteria for director nominees, although the Board may also consider such other factors as it may deem are in our best interests as well as our stockholders. In addition, the Board identifies nominees by first evaluating the current members of the Board willing to continue in service. Current members of the Board with skills and experience that are relevant to our business andwhoare willing to continue in service are considered for re-nomination. If any member of the Board does not wish to continue in service or if the Board decides not to re-nominate a member for re-election, the Board then identifies the desired skills and experience of a new nominee in light of the criteria above. Current members of the Board are polled for suggestions as to individuals meeting the criteria described above. The Board may also engage in research to identify qualified individuals. To date,wehave not engaged third parties to identify or evaluate or assist in identifying potential nominees, althoughwereserve the right in the future to retain a third-party search firm, if necessary. The Board does not typically consider shareholder nominees because it believes that its current nomination process is sufficient to identify directorswhoserve our best interests.

In March 2018 the Board of Directors formed an informal Advisory Board consisting of non-employee members who provide advice to the Board of Directors. Gerry David, Kevin Harrington, and Hal Kravitz are currently members of the Advisory Board.

In August 2017 the Company adopted a Code of Conduct for all directors, officers, employees, and contractors.

In 2013, the Company entered into a ten-year employment agreement with Jerry Grisaffi, Chairman of the Board of Directors. Under the agreement, we agreed to compensate Mr. Grisaffi at a rate of $125,000 per year and to a bonus of $30,000 annually, or a greater amount as approved by the Company's Board of Directors. We also issued 10,000,000 shares of Series A preferred stock, 1,000,000 shares of Series B preferred stock, and 1,500,000,000 shares of restricted common stock to Mr. Grisaffi under the terms of the agreement. In June 2017, the Company and Mr. Grisaffi entered into an Indemnification and Release Agreement whereby both parties agreed to mutually release each other from the terms of Mr. Grisaffi’s employment agreement. The Company is seeking to void the Indemnification and Release Agreement.

In 2014, the Company entered into a five-year employment agreement with David M. Seeberger, Vice President and General Counsel. Under the agreement,weagreed to compensate Mr. Seeberger at a rate of $120,000 per year and to bonus obligations based on the profitability of the Company. We also agreed to grant Mr. Seeberger an option to purchase 2,000,000 shares of common stock for par value at any time after January 1, 2015. On February 1, 2018, the Company entered into a new three-year employment agreement with Mr. Seeberger. The new agreement includes base compensation of $120,000 per year and discretionary bonuses as approved by the Board of Directors.

In January 2016, the Company entered into a five-year employment agreement with Michael Welch, Chief Financial Officer. Under the agreement,weagreed to compensate Mr. Welch at a rate of $120,000 per year and to pay a bonus based on the profitability of the Company. Mr. Welch also became Chief Executive Officer on March 1, 2016. His salary was increased to $150,000 per year. In addition, Mr. Welch received 10,000,000 warrants for common stock at a price of $.001 on January 4, 2016 that were exercisable on July 25, 2016. On February 1, 2018, the Company entered into a new three-year employment agreement with Mr. Welch. The new agreement includes base compensation of $150,000 per year and discretionary bonuses as approved by the Board of Directors.

On December 18, 2017, the Company entered into a five-year employment agreement with John Blackington, Chief Commercialization Officer. The agreement includes base compensation of $140,000 per year, 7,000,000 common stock options, an annual bonus of up to 30%, and discretionary bonuses as approved by the Board of Directors.

On February 1, 2018, the Company entered into a three-year employment agreement with Jens Mielke, Chief Financial Officer. The agreement includes base compensation of $140,000 per year and discretionary bonuses as approved by the Board of Directors.

On February 1, 2018, the Company entered into a three-year employment agreement with Charles Smith, Chief Operating Officer. The agreement includes base compensation of $120,000 per year and discretionary bonuses as approved by the Board of Directors.

The following table sets forth the compensation earned by Executive Officers during the six months ended December 31, 2017 and 2016:

The Company paid its officers as 1099 Contractors during the first two quarters of 2016 due to the shortage of operating cash in the company during those time periods. All officers were converted to payroll during the third quarter of fiscal year 2016.

The table below summarizes all unexercised options, stock that has not vested, and equity incentive plan awards for each named Executive Officer as of December 31, 2017:

The table below summarizes all compensation paid to our Directors during the six months ended December 31, 2017:

The following table sets forth, as of ~~June 5,~~October 4, 2018, the beneficial ownership of the Company’s capital stock by each Executive Officer and Director, by each person known to beneficially own more than 5% of our common stock and by the executive officers and directors as a group. Except as otherwise indicated, all shares are owned directly and the percentage shown is based on ~~1,629,825,101~~1,719,504,073 shares of common stock issued and outstanding.

Title of class	Name and address of beneficial owner(1)	Amount of beneficial ownership	Percent of class(2)	Percent of Voting Power (3)	Name and address of beneficial owner(1)	Amount of beneficial ownership	Percent of class(2)	Percent of Voting Power (3)
Current Executive Officers & Directors:	Current Executive Officers & Directors:				Current Executive Officers & Directors:
Common Stock	Michael R. Welch 10626 Cox Lane Dallas, TX 75229	26,836,071	1.55%	1.32%
Common Stock	Jens R. Mielke 4403 Vandelia St. Dallas, TX 75219	9,743,153	0.56%	0.48%	Michael R. Welch 10626 Cox Lane Dallas, TX 75229	26,836,071	1.56%	1.27%
Common Stock	Charles Smith 479 Medina Dr. Highland Village, TX 75077	18,042,839	1.01%	.89%	Jens R. Mielke 4403 Vandelia St. Dallas, TX 75219	9,743,153	0.57%	0.46%
Common Stock	David M. Seeberger 1252 N. Selva Dallas, TX 75218	25,261,241	1.46%	1.24%	Charles Smith 479 Medina Dr. Highland Village, TX 75077	18,042,839	1.05%	.85%
Common Stock	John T. Blackington, Jr. 2905 Amesbury Dr. Plano, TX 75093	5,609,982	.32%	.28%	David M. Seeberger 1252 N. Selva Dallas, TX 75218	25,261,241	1.47%	1.19%
Common Stock	Winton Morrison 277 Driftwood Rd., SE St. Petersburg, FL 33705	13,295,667	.76%	0.66%	John T. Blackington, Jr. 2905 Amesbury Dr. Plano, TX 75093	5,609,982	.33%	.26%
Common Stock	Lily Li(4) 4858 Route 32 Catskill, NY 12414	116,000,000	6.71%	20.49%	Winton Morrison 277 Driftwood Rd., SE St. Petersburg, FL 33705	13,295,667	.77%	0.63%
Common Stock	Dean Blythe (6) 11059 Windjammer Dr. Frisco, TX 75034	2,000,000	.12%	0.1%	Dean Blythe (6) 11059 Windjammer Dr. Frisco, TX 75034	2,000,000	.12%	0.09%
Common Stock Total of All Current Directors and Officers:	Common Stock Total of All Current Directors and Officers:	216,788,953	12.53%	25.46%	Common Stock Total of All Current Directors and Officers:	100,788,953	5.87%	4.75%

More than 5% Beneficial Owners	More than 5% Beneficial Owners				More than 5% Beneficial Owners
Series A Preferred Stock	LSW Holdings, LLC(5)	1,000,000	100%	19.71%	LSW Holdings, LLC(5)	1,000,000	100%	18.87%

Except as described below, there have been no transactions or presently proposed transactions since our incorporation to whichwehave been a participant in which: (1) the amount involved exceeded or will exceed the lesser of: (i) $120,000, or (ii) one percent of the average of our total assets at year-end for the lasttwo completed fiscal years; and (2) any of our directors or executive officers, nor any proposed nominee for election as a director, nor any personwhobeneficially owns, directly or indirectly, more than 5% of any class of our voting securities, nor any members of the immediate family (including spouse, parents, children, siblings, and in-laws) of any of the foregoing persons, has any material interest, direct or indirect:

We are not a “listed issuer” within the meaning of Item 407 of Regulation S-K and there are no applicable listing standards for determining the independence of our directors. Applying the definition of independence set forth in Rule 4200(a)(15) of The NASDAQ Stock Market, Inc.,wehave two independent directors, Winton Morrison and Dean Blythe.

Our Articles of Incorporation authorize 4,000,000,000 shares of common stock, of which ~~1,629,825,101~~1,719,504,073 are outstanding as of ~~June 21,~~October 4, 2018; 1,000,000 shares of series A preferred stock, of which 1,000,000 shares are outstanding as of June 5, 2018; 7,000,000 shares of series B preferred stock, of which none are outstanding; 2,000,000 shares of series C preferred stock, of which none are outstanding; 2,000,000 of series D preferred stock, of which none are outstanding; and 789,474 shares of Series E Preferred Stock, of which none are outstanding.

As of ~~June 21,~~October 4, 2018, there were ~~1,629,825,101~~1,719,504,073 shares of our common stock issued and outstanding. Our common stock is entitled to one vote per share on all matters submitted to a vote of the stockholders, including the election of directors. Except as otherwise required by law or provided in any resolution adopted by our board of directors with respect to any series of preferred stock, the holders of our common stock will possess all voting power. Generally, all matters to be voted on by stockholders must be approved by a majority (or, in the case of election of directors, by a plurality) of the votes entitled to be cast by all shares of our common stock that are present in person or represented by proxy, subject to any voting rights granted to holders of any preferred stock. Holders of our common stock representing fifty percent (50%) of our capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any meeting of our stockholders. A vote by the holders of a majority of our outstanding shares is required to effectuate certain fundamental corporate changes such as liquidation, merger or an amendment to our Articles of Incorporation. Our Articles of Incorporation do not provide for cumulative voting in the election of directors.

Subject to any preferential rights of any outstanding series of preferred stock created by our board of directors from time to time, the holders of shares of our common stock will be entitled to such cash dividends as may be declared from time to time by our board of directors from funds available therefore.

Subject to any preferential rights of any outstanding series of preferred stock created from time to time by our board of directors, upon liquidation, dissolution or winding up, the holders of shares of our common stock will be entitled to receive pro rata all assets available for distribution to such holders.

In the event of any merger or consolidation with or into another company in connection with which shares of our common stock are converted into or exchangeable for shares of stock, other securities or property (including cash), all holders of our common stock will be entitled to receive the same kind and amount of shares of stock and other securities and property (including cash). Holders of our common stock have no pre-emptive rights, no conversion rights, and there are no redemption provisions applicable to our common stock.

Our class of Series A Preferred Stock consists of one million authorized shares. Holders of Series A Preferred Stock are entitled to cast four hundred (400) votes for every one (1) share of Series A Preferred Stock held. All shares of Series A Preferred Stock are convertible to common stock at a ratio of 100 for 1.

As of June 5, 2018, there were warrants to purchase 650,000 shares of common stock outstanding, and options to purchase liquidation, dissolution or winding up, the holders of shares of our common stock will be entitled to receive pro rata all assets available for distribution to such holders.an additional 36,630,104 shares of common stock. In addition, there were outstanding convertible notes in the total amount of $1,368,112, with an average conversion price of $.006 per share.

Neither our articles of incorporation, norourbylaws, prevent us from indemnifying our officers, directors and agents to the extent permitted under the Nevada Revised Statutes (“NRS”). NRS Section 78.7502, provides that a corporation may indemnify any director, officer, employee or agent of a corporation against expenses, including fees, actually and reasonably incurred by him in connection with any defense to the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue or matter therein.

NRS 78.7502(1) provides that a corporation may indemnify any personwhowas or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.

NRS Section 78.7502(2) provides that a corporation may indemnify any personwhowas or is a party or is threatened to be made a party any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there from, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

NRS Section 78.747 provides that except as otherwise provided by specific statute, no director or officer of a corporation is alter ego of the corporation. The court as a matter of law must determine the question of whether a director or officer acts as the alter ego of a corporation.

Our charter provides that we liquidation, dissolution or winding up, the holders of shares of our common stock will be entitled to receive pro rata all assets available for distribution to such holders.will indemnify our directors, officers, employees and agents to the extent and in the manner permitted by the provisions of the NRS, as amended from time to time, subject to any permissible expansion or limitation of such indemnification, as may be set forth in any stockholders’ or directors’ resolution or by contract. Any repeal or modification of these provisions approved by our stockholders will be prospective only and will not adversely affect any limitation on the liability of any of our directors or officers existing as of the time of such repeal or modification. We are also permitted to apply for insurance on behalf of any director, officer, employee or other agent for liability arising out of his actions, whether or not the NRS would permit indemnification.

Our bylaws provide that a director or officer of the Company shall have no personal liability to the Company or its stockholders for damages for breach of fiduciary duty as a director or officer, except for damages for breach of fiduciary duty resulting from (a) acts or omissions which involve intentional misconduct, fraud, or a knowing violation of law, or (b) the payment of dividends in violation of section 78.3900 of the NRS as it may from time to time be amended or any successor provision thereto.

The transfer agent and registrar for our common stock and preferred stock is Signature Stock Transfer. Its address is 14673 Midway Rd., Ste. 220,Addison, TX 75001 and its telephone number is (972) 612-4120.

The selling stockholdermay,from time to time, sell any or all of its shares of Company common stock on OTC Markets or any other stock exchange, market or trading facility on which the shares of our common stock are traded, or in private transactions. These sales may be at fixed prices, prevailing market prices at the time of sale, at varying prices, or at negotiated prices. The selling stockholder may use any one or more of the following methods when selling shares:

Additionally, broker-dealers engaged by the selling stockholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholder (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commissions in compliance with FINRA Rule 2440; and in the case of a principal transaction, a markup or markdown in compliance with FINRA IM-2440.

GHS is an underwriter within the meaning of the Securities Act of 1933, and any broker-dealers or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities Act of 1933 in connection with such sales. Any commissions received by such broker-dealers or agents, and any profit on the resale of the shares purchased by them, may be deemed to be underwriting commissions or discounts under the Securities Act of 1933. GHS has informed us that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the Company’s common stock. Pursuant to a requirement by FINRA, the maximum commission or discount to be received by any FINRA member or independent broker-dealer may not be greater than 8% of the gross proceeds received by us for the sale of any securities being registered pursuant to Rule 415 promulgated under the Securities Act of 1933.

Discounts, concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by the selling stockholder. The selling stockholder may agree to indemnify any agent, dealer, or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person under the Securities Act of 1933.

We are required to pay certain fees and expenses incurred by us incident to the registration of the shares covered by this prospectus. We have agreed to indemnify the selling stockholder against certain losses, claims, damages and liabilities, including liabilities under the Securities Act of 1933. We will not receive any proceeds from the resale of any of the shares of our common stock by the selling stockholder. We will receive proceeds from the sale of our common stock to GHS under the Securities Purchase Agreement. Neither the Securities Purchase Agreement with GHS nor any rights of the parties under the Securities Purchase Agreement with GHS may be assigned or delegated to any other person.

We have entered into an agreement with GHS to keep this prospectus effective until GHS (i) has sold all of the common shares purchased by it under the Securities Purchase Agreement and (ii) has no further right to acquire any additional shares of common stock under the Securities Purchase Agreement.

The resale shares will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale shares may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

Under applicable rules and regulations under the Securities Exchange Act of 1934, any person engaged in the distribution of the resale shares may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Securities Exchange Act of 1934 and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of shares of the common stock by the selling stockholder or any other person. We will make copies of this prospectus available to the selling stockholder.

The validity of the securities being offered by this prospectus has been passed upon for us by Laxague Law, Inc., Reno, NV.

The consolidated financial statements of Rocky Mountain High Brands, Inc. as of December 31, 2017, June 30, 2017 and June 30, 2016 have been so included in reliance on the report of Paritz & Company, P.A., an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

We are a reporting company and file annual, quarterly and special reports, and other information with the SEC. Copies of the reports and other information may be read and copied at the SEC’s Public Reference Room at 100 F Street N.E., Washington, D.C. 20549. You can request copies of such documents by writing to the SEC and paying a fee for the copying cost. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a web site athttp://www.sec.govthat contains reports, proxy and information statements, and other information regarding registrants that file electronically with the SEC.

This prospectus is part of a registration statement on Form S-1 that we filed with the SEC. Certain information in the registration statement has been omitted from this prospectus in accordance with the rules and regulations of the SEC. We have also filed exhibits and schedules with the registration statement that are excluded from this prospectus. For further information you may:

The Accompanying Notes are an Integral Part of the Consolidated Financial Statements

The Accompanying Notes are an Integral Part of the Consolidated Financial Statements.

Rocky Mountain High Brands, Inc. (“RMHB” or the “Company”) was incorporated under the laws of the State of Nevada. On July 17, 2014, the Company changed its name from Republic of Texas Brands Incorporated to Totally Hemp Crazy, Inc and on October 23, 2015, the Company changed its name to Rocky Mountain High Brands, Inc.

RMHB currently operates through its parent company, five wholly-owned subsidiaries and one minority-owned subsidiary, which the Company controls. All subsidiaries are consolidated for financial reporting purposes.

RMHB is a consumer goods company that specializes in developing, manufacturing, marketing, and distributing high-quality, health conscious, cannabidiol (“CBD”) and hemp- infused products that span various categories including beverage, food, fitness, skin care and more. RMHB also markets a naturally high alkaline spring water as part of our brand portfolio.

In March 2018, the Company launched the HEMPd brand with tinctures, gummies, water soluble drops, capsules, lotions, salves, and and E-juice liquids. The Company plans to introduce CBD-infused waters and additional HEMPd product offerings during the remainder of 2018. HEMPd products are marketed through the Company’s Rocky Mountain Hemp Company subsidiary. Customer shipments of HEMPd products began in late March 2018.

The Company continues to market a lineup of two naturally flavored hemp-infused functional beverages, Citrus Energy and Mango Energy. RMHB also bottles and distributes its naturally high alkaline spring water under the name Eagle Spirit Spring Water.

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2018 and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2018 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Company’s form 10-KT for the transition period ended December 31, 2017 filed with the SEC on April 2, 2018.

The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. The consolidated financial statements include the accounts of the Company, its wholly-owned and controlled subsidiaries. All intercompany balances and transactions have been eliminated.

The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents.

The Company follows the guidance of the Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers,” as amended. It records revenue when persuasive evidence of an arrangement exists, product delivery has occurred, the selling price to the customer is fixed or determinable and collectability of the revenue is reasonably assured. The Company has not experienced any significant returns from customers and accordingly, in management’s opinion, no reserve for returns has been provided. Payments received prior to shipment of goods are recorded as deferred revenue.

Inventories, which consist only of the Company’s finished products held for resale, are stated at the lower of cost, determined using the first-in, first-out, and net realizable value. Net realizable value is the estimated selling price, in the ordinary course of business, less estimated costs to dispose of the product.

The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures,” which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.

The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of our short and long term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.

The estimated fair value of the derivative instruments were valued using the Black-Scholes option pricing model, using the following assumptions as of June 30, 2018:

Direct costs related to software development, including coding, website application development, infrastructure development and graphics development, are capitalized and included in other assets. Amortization is provided for on a straight-line basis over the useful life of the software. Costs related to planning, content development, and operating and maintaining software are expensed as incurred.

We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classified our preferred shares in stockholders’ equity. Our preferred shares do not feature any redemption rights within the holders’ control or conditional redemption features not within our control. Accordingly, unless otherwise noted, all issuances of preferred stock are presented as a component of consolidated shareholders’ deficit.

The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.

ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has no material uncertain tax positions.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has a shareholders’ deficit of $1,126,057 and an accumulated deficit of $35,372,273 as of June 30, 2018 and has generated operating losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue raising capital.

On June 27, 2018, the Company entered into a Securities Purchase Agreement (“SPA”) with GHS Investments, LLC (“GHS”), which provides for GHS to purchase up to $15,000,000 of the Company’s common stock over a 24-month period based on a contractually agreed upon market discount. The SPA replaces the Equity Financing Agreement the Company entered into with GHS on October 12, 2017. On August 8, 2018, the Company filed a registration statement with the Securities and Exchange Commission (“SEC”) to register up to 320,000,000 shares of our common stock to be purchased by GHS under the SPA. Management believes the SPA will provide sufficient cash flows until cash flows from operations become consistently positive.

As of June 30, 2018 and December 31, 2017, inventory consisted of the following:

As of June 30, 2018 and December 31, 2017, prepaid expenses and other current assets were as follows:

On June 29, 2018 the Company loaned BFIT Brands, LLC (“BFIT”), an Arizona limited liability company, $80,000 at 8% interest for a term of nine months. The note included an option to purchase the assets of BFIT.

As of June 30, 2018 and December 31, 2017, property and equipment were as follows:

For the three months ended June 30, 2018 and 2017, depreciation expense was $5,448 and $4,838, respectively. For the six months ended June 30, 2018 and 2017, depreciation expense was $10,129 and $12,095, respectively.

As of June 30, 2018 and December 31, 2017, accounts payable and accrued liabilities consisted of the following:

As of June 30, 2018 and December 31, 2017, the Company’s convertible notes payable were as follows:

For the three months ended June 30, 2018 and 2017, interest expense on these notes, including amortization of the discount, was $365,011 and $58,107, respectively. For the six months ended June 30, 2018 and 2017, interest expense on these notes, including amortization of the discount, was $740,526 and $94,851, respectively.

The Company has determined that the conversion feature embedded in certain of the notes referred to above that contain a potential variable conversion amount constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt. The excess of the derivative value over the face amount of the note is recorded immediately to interest expense at inception. The Company recorded no interest expense for the three and six months ended June 30, 2018 and 2017, respectively, relating to the excess of derivative value over the face amount of convertible notes payable.

The Company recorded no interest expense for the three months ended June 30, 2018 and 2017, respectively, at the inception of certain convertible notes payable relating to the excess of the beneficial conversion feature over the face amount of the related convertible notes payable. The Company recorded $2,432,909 and $0 interest expense for the six months ended June 30, 2018 and 2017, respectively, at the inception of certain convertible notes payable relating to the excess of the beneficial conversion feature over the face amount of the related convertible notes payable.

On November 30, 2017 the Company amended two notes payable to GHS in the aggregate principal amount of $500,000. The notes, which were originally made on October 12 and November 2, 2017 and included conversion prices at a 20% discount off market price, as defined in the agreements. The amendments removed the conversion features in the notes. Upon amendment, the Company recorded a loss on extinguishment of these notes of $15,256. As of December 31, 2017 the notes, which were previously included in Convertible Notes Payable are included in Notes Payable. On January 9, 2018 the notes were again amended to reinstate the conversion feature. These notes are included in Convertible Notes Payable as of June 30, 2018.

For the three months ended June 30, 2018 and 2017, interest expense on these notes was $559 and $416, respectively. For the six months ended June 30, 2018 and 2017, interest expense on these notes was $1,220 and $1,045, respectively.

As of June 30, 2018 and 2017, the Company’s related party convertible notes payable were as follows:

For the three months ended June 30, 2018 and 2017, interest expense on these notes, including amortization of the discount, was $0 and $121,199, respectively. For the six months ended June 30, 2018 and 2017, interest expense on these notes, including amortization of the discount, was $8,043 and $337,852, respectively.

The Company has determined that the conversion feature embedded in certain of the notes referred to above that contain a potential variable conversion amount constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt. The excess of the derivative value over the face amount of the note is recorded immediately to interest expense at inception. The Company recorded no interest expense for the three and six months ended June 30, 2018 and 2017, respectively, at the inception of the notes relating to the excess of derivative value over the face of the notes.

The balance of these notes was reclassified to convertible notes payable as of April 5, 2018 upon the termination of the Company’s Executive Vice President, Lily Li, who is the Managing Member of LSW Holdings, LLC (“LSW”), the holder of these notes.

As of June 30, 2018 the Company has 4,000,000,000 shares of common stock authorized.

During the six months ended June 30, 2018 the Company issued 470,892,871 shares of common stock, including 178,160,074 shares for convertible notes payable conversions, 244,217,685 shares for cash, 29,096,402 shares for option exercises and 19,418,710 shares for services rendered.

The Company has 20,000,000 shares of preferred stock authorized as of June 30, 2018, of which 12,789,474 are specifically designated to a series of preferred stock and 7,210,526 remain undesignated.

The Company has 1,000,000 shares of Series A Preferred Stock designated and outstanding as of June 30, 2018 and December 31, 2017. LSW is the holder of these shares. Lily Li, who was the Company’s Executive Vice President until April 5, 2018, is the Managing Member of LSW and, in that capacity, has the authority to direct voting and investment decisions with regard to its holdings in the Company.

The Company has 7,000,000 shares of Series B Preferred Stock designated, of which none were outstanding as of June 30, 2018 and December 31, 2017.

The Company has 2,000,000 shares of Series C Preferred Stock designated, of which none were outstanding as of June 30, 2018 and December 31, 2017. Series C Preferred Stock is 12% interest bearing, cumulative, exchangeable, non-voting, convertible preferred stock of the Company. Each Series C Preferred share is convertible to 50 shares of common stock.

The Company has 2,000,000 shares of Series D Preferred Stock designated, of which none were outstanding as of June 30, 2018 and December 31, 2017. Series D Preferred Stock is a non-voting, non-interest bearing convertible preferred stock. Each Series D preferred share is convertible to 100 shares of common stock.

On September 19, 2017, the Board of Directors approved a new Series E Preferred Stock. Holders of Series E Preferred Stock are entitled to cast 2,000 votes per share of Series E Preferred Stock on any proposal to increase our authorized capital stock, with no other voting rights. Series E Preferred Stock is convertible to common stock on a 1:1 basis. On the same day, the Board granted our Chairman 789,474 shares of Series E Preferred stock as payment for his deferred compensation. On October 31, 2017, Mr. Welch converted his 789,474 shares of Series E Preferred Stock to 789,474 shares of common stock. As of June 30, 2018 and December 31, 2017 there were no shares outstanding.

During the six months ended June 30, 2018 the Company granted no common stock warrants, none were exercised, and none were cancelled.

During the six months ended June 30, 2018 the Company granted 5,624,789 options to purchase common stock with terms ranging from two to five years and exercise prices of $.003, holders exercised 23,607,193 options, and none were cancelled.

During the three months ended June 30, 2018 the Company’s two largest customers accounted for approximately 16% and 3% of sales, respectively. During the three months ended June 30, 2017, the Company’s two largest customers accounted for approximately 15% and 3% of sales, respectively. During the six months ended June 30, 2018 the Company’s two largest customers accounted for approximately 9% and 12% of sales, respectively. During the six months ended June 30, 2017, the Company’s two largest customers accounted for approximately 19% and 9% of sales, respectively.

The reconciliation of income tax benefit at the U.S. statutory rate of 21% to the Company’s effective rate for the periods presented is as follows:

The tax effects of temporary differences that give rise to the Company’s net deferred tax liability as of June 30, 2018 and December 31, 2017 are as follows:

As of June 30, 2018 the Company had approximately $18,000,000 of federal and state net operating loss carryovers (“NOLs”), which begin to expire in 2028. Utilization of the NOLs may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under regulations.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against the entire deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized.

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) was signed into law making significant changes to the Internal Revenue Code. Changes include, but are not limited to, a federal corporate tax rate decrease from 35% to 21% for tax years beginning after December 31, 2017, the transition of U.S international taxation from a worldwide tax system to a territorial system, and a one-time transition tax on the mandatory deemed repatriation of foreign earnings. We have estimated our provision for income taxes in accordance with the Tax Act and guidance available as of the date of this filing but have kept the full valuation allowance. As a result the Company has recorded no income tax expense during the three and six months ended June 30, 2018.

The Company’s deferred tax assets and liabilities were remeasured to reflect the reduction in the U.S. corporate income tax rate from 34% to 21%, resulting in a deferred tax expense of approximately $2,000,000 in 2017 that is still fully valued against as of June 30, 2018. This expense is attributable to the Company being in a net deferred tax asset position at the time of remeasurement. As the company maintains fully valuation allowance, this amount can be seen on the rate reconciliation as an adjustment to deferred tax asset and corresponding valuation allowance.

On December 22, 2017, Staff Accounting Bulletin No. 118 (“SAB 118”) was issued to address the application of US GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Act. The deferred tax expense recorded in connection with the remeasurement of deferred tax assets is a provisional amount and a reasonable estimate at December 31, 2017 based upon the best information currently available. The ultimate impact may differ from these provisional amounts, possibly materially, due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the Tax Act. Any subsequent adjustment to these amounts will be recorded to current tax expense in the quarter of 2018 when the analysis is complete. The accounting is expected to be complete when the 2017 U.S. corporate income tax return is filed in 2018.

The Company has a three-year lease for corporate office space. The lease commenced on September 1, 2016 with monthly payments of $7,715 in year one, $7,972 in year two and $8,229 in year three. The lease is being accounted for on a straight-line basis over its term.

On January 18, 2018, the RMHC entered into a 12-month office use agreement for office space in Denver, Colorado. Monthly payments are $91.

The Company rents storage space from various third parties on a month-to-month basis.

Please refer to our Transition Report on Form 10-KT filed April 2, 2018 for information regarding our pending legal proceedings. The following represents an update to the items disclosed in that filing:

Rocky Mountain High Brands, Inc. v Lyonpride Music, LLC, United States District Court Northern District of Texas, 3:18-cv-00045-C

Los Angeles Superior Court, BC669367, filed July 24, 2017. Statewide Beverage Company, Inc. v. Rocky Mountain High Brands, Inc.

Statewide Beverage Company, Inc. filed a breach of contract claim, and the Company has filed counterclaims for breach of contract, common law fraud and declaratory relief. The case is currently in the discovery phase.

On May 3, 2018 the Trial Court conducted a hearing on motion by the Company and issued orders directing LSW Holdings, LLC (“LSW”) and Lily Li (“Li”) to respond to discovery propounded by the Company and sanctioned LSW and Li for failure to properly and timely respond to such discovery. On June 20, 2018, the Trial Court conducted a hearing on motion by the Company and issued an order directing Grisaffi to respond to discovery propounded by the Company and sanctioned Grisaffi for failure to properly and timely respond to such discovery. The Company is awaiting full response and production from all defendants.

Between July 1, 2018 and August 15, 2018, the Company issued 28,282,315 shares of common stock, of which 5,782,315 were for cash and 22,500,000 were for debt conversions.

On July 24, 2018 the Company executed a $157,500 convertible note payable with GHS. On August 13, 2018 the Company executed a $157,500 convertible note payable with GHS. Both notes have nine month terms and include a fixed conversion rate of $.008 and can be prepaid at any time.

On July 25, 2018 the Company acquired the assets of BFIT Brands, LLC, (“BFIT”) an Arizona limited liability company. These assets include the cash, accounts receivable, inventory, FitWhey trademark, recipes and formulas of BFIT’s FitWhey branded water-based protein drinks containing caffeine and a vitamin B pack. The Company paid total consideration of $230,000 including forgiveness of an $80,000 note receivable from BFIT, $75,000 in common stock and $75,000 in cash to be paid out to BFIT owners over time based on 5% of revenues. On August 2, 2018, the Company organized a new wholly-owned subsidiary, FitWhey Brands, Inc. (“FitWhey”) to operate the acquired business.

We have audited the accompanying consolidated balance sheets of Rocky Mountain Brands, Inc. (the Company) as of December 31, 2017 and June 30, 2017 and 2016, and the related consolidated statements of operations, stockholders’ deficit, and cash flows for the six months ended December 31, 2017 and each of the two years in the period ended June 30, 2017, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and June 30, 2017 and 2016, and the results of its operations and its cash flows for the six months ended December 31, 2017 and each of the two years in the period ended June 30, 2017, in conformity with accounting principles generally accepted in the United States of America.

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 3 to the consolidated financial statements, the Company has a shareholders’ deficit of $7,041,899, an accumulated deficit of $31,662,414, and a working capital deficit of $7,106,673 as of December 31, 2017, and has generated operating losses since inception. These factors, among others, raise substantial doubt regarding the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 3 to the accompanying financial statements. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Accompanying Notes are an Integral Part of the Consolidated Financial Statements

Consolidated Statements of Shareholders' Deficit for the Six Months Ended December 31, 2017

Consolidated Statements of Shareholders' Deficit for the Six Months Ended December 31, 2016

The Accompanying Notes are an Integral Part of the Consolidated Financial Statements

Consolidated Statements of Shareholders' Deficit for the Year Ended June 30, 2016 and 2017

The Accompanying Notes are an Integral Part of the Consolidated Financial Statements

Rocky Mountain High Brands, Inc. (“RMHB” or the “Company”) was incorporated under the laws of the State of Nevada. On July 17, 2014, the Company changed its name from Republic of Texas Brands Incorporated to Totally Hemp Crazy, Inc and on October 23, 2014, the Company changed its name to Rocky Mountain High Brands, Inc.

RMHB currently operates four wholly-owned subsidiaries and one 49% owned subsidiary, which the Company controls. All subsidiaries are consolidated for financial reporting purposes.

RMHB is a consumer goods company that specializes in developing, manufacturing, marketing, and distributing high-quality, health conscious, cannabidiol (“CBD”) and hemp- infused products that span various categories including beverage, food, fitness, skin care and more. RMHB also markets a naturally high alkaline spring water as part of our brand portfolio.

The Company continues to market its lineup of four naturally flavored hemp-infused functional beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink, as well as hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. RMHB also bottles and distributes its naturally high alkaline spring water under the name Eagle Spirit Spring Water.

The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents.

The Company evaluates intangible assets for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flow and recognizes an impairment loss when the estimated undiscounted future cash flow expected to result from the use of the asset plus the net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. When the Company identifies an impairment, it reduces the carrying amount of the asset to its estimated fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values. During the six months ended December 31, 2017 the Company recorded an impairment charge on the goodwill related to the acquisition of Rocky Mountain High Water Company in the amount of $59,163. As of December 31, 2017 the goodwill related to this acquisition is fully impaired. No impairment charges were recorded during the year ended June 30, 2017 or the six months ended December 31, 2016. During the year ended June 30, 2016 the Company recorded a 100% impairment of $166,000 on its investment in Dollar Shots Club when it was determined that the Company would not likely recover its investment.

We apply the guidance enumerated in ASC 480 “Distinguishing Liabilities from Equity” when determining the classification and measurement of preferred stock. Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. We classify conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, we classified our preferred shares in stockholders’ equity. Our preferred shares do not feature any redemption rights within the holders’ control or conditional redemption features not within our control. Accordingly, unless otherwise noted, all issuances of preferred stock are presented as a component of consolidated stockholders’ equity (deficit).

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has a shareholders’ deficit of $7,041,899, an accumulated deficit of $31,662,414, and a working capital deficit of $7,106,673 as of December 31, 2017, and has generated operating losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue raising capital from third parties.

On October 12, 2017, the Company entered into an Equity Financing Agreement (“EFA”) with GHS Investments, LLC (“GHS”), which provides for GHS to purchase up to $12,000,000 of the Company’s common stock over a 24-month period based on a contractually agreed upon market discount. In February 2018 the Company began sales of common stock to GHS under the EFA. Management believes the EFA will provide sufficient cash flows until cash flows from operations become consistently positive.

As of December 31, 2017, June 30, 2017, and June 30, 2016, inventory consists of the following:

As of December 31, 2017, June 30, 2017, and June 30, 2016, prepaid expenses and other current assets consists of the following:

As of December 31, 2017, June 30, 2017, and June 30, 2016, property and equipment consists of the following:

On November 12, 2016, the agreement with the Poafpybitty Family was amended to give the Company a controlling voting interest of 75% of WaterCo, while the Poafpybitty Family received 51% of the equity interest. The amended agreement is being accounted for as a step-acquisition, with the resulting goodwill of $59,163 included in other assets. During the six months ended December 31, 2017, the Company obtained an outside valuation of the rights to use the land and obtain the water described in the agreement. As a result of that analysis and the continued operating losses by the Company’s spring water business, the Company determined that its investment, including the related goodwill, was fully impaired. The Company recorded an impairment expense of $59,163 as of November 12, 2017. As a result of the step-acquisition, beginning on November 12, 2016 the operations of WaterCo are consolidated in the financial statements of RMHB.

On September 18, 2015, the Company, through a series of transactions acquired 5,000,000 shares of Dollar Shots Club, Inc. (“DSC”) in exchange for 2,000,000 shares of common stock. The shares of DSC are being carried on the accompanying balance sheet based on the value of the shares of stock given in exchange for the investment. The Company is accounting for the investment on the cost basis of accounting being that the shares represent approximately 5% of the total outstanding shares of DSC and the Company does not have any significant influence in DSC.

As of June 30, 2016, the Company concluded that the investment was impaired and recorded a 100% impairment on this investment of$166,000.

As of December 31, 2017, June 30, 2017, and June 30, 2016, accounts payable and accrued liabilities consists of the following:

As of December 31, 2017, June 30, 2017, and June 30, 2016, the Company’s related party convertible notes payable consists of the following:

As of December 31, 2017, the related party convertible notes represent two notes payable to LSW in the amounts of $79,000 and $100,000. They are convertible to shares of the Company’s common stock at 50% of market price, as defined in the notes payable agreements.

The Company has determined that the conversion feature embedded in the notes referred to above that contain a potential variable conversion amount constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt. The excess of the derivative value over the face amount of the note is recorded immediately to interest expense at inception. The Company recorded no interest expense for the six months ended December 31, 2017 and December 31, 2016 at the inception of the notes relating to the excess of derivative value over the face of the notes. The Company recorded $44,901 and $0 of interest expense for the years ended June 30, 2017 and 2016, respectively, at the inception of the notes relating to the excess of derivative value over the face of the notes.

As of June 30, 2017, Jerry Grisaffi, our former Chairman of the Board, held two notes payable with principal amounts of $200,150 and $184,300. The $200,150 note, which was due on December 19, 2017, converts at 50% of the average of the 3 lowest bid prices of the common stock during the 10 days prior to the conversion. The $184,300 note, which was renewed through December 30, 2017, is convertible at $.01 with an anti-dilutive clause that becomes effective with any dilution of the Company’s common stock greater than 1% of the shares outstanding at the time of split. Both notes accrue interest at 6%. As of December 31, 2017, these notes are reclassified to Convertible Notes Payable as Mr. Grisaffi is no longer a related party. Both of Mr. Grisaffi’s convertible notes payable are subject to a lawsuit brought by the Company against Mr. Grisaffi.

For the six months ended December 31, 2017 and December 31, 2016, interest expense on these notes, including amortization of the discount, was $262,613 and $160,089, respectively. For the years ended June 30, 2017 and 2016, interest expense on these notes, including amortization of the discount, was $337,852 and $16,308, respectively.

As of December 31, 2017, June 30, 2017, and June 30, 2016, the Company’s convertible notes payable consisted of the following:

The convertible notes are convertible to shares of the Company’s common stock at $.005 to 50% of the market price, as defined in the agreements. For the six months endedDecember 31, 2017 and 2016, interest expense on these notes, including amortization of the discount, was $543,164 and $77,743, respectively. For the years ended June 30, 2017 and 2016, interest expense on these notes, including amortization of the discount, was $172,594 and $26,762, respectively.

The Company has determined that the conversion feature embedded in the notes referred to above that contain a potential variable conversion amount constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt. The excess of the derivative value over the face amount of the note is recorded immediately to interest expense at inception. The Company recorded $1,179,140 and $0 of interest expense for the six months ended December 31, 2017 and 2016, respectively, at the inception of the notes relating to the excess of derivative value over the face of the notes. The Company recorded $222,127 and $0 of interest expense for the years ended June 30, 2017 and 2016, respectively, at the inception of the notes relating to the excess of derivative value over the face of the notes.

During the six months ended December 31, 2017, the Company recorded a gain on extinguishment of debt of $1,200,092. This gain consists of the gain on the extinguishment of debt related to the legal settlement with a debt holder of $1,811,714, the gain on the assignment and subsequent amendment of a convertible note payable of $333,899, the loss on conversion of certain convertible notes payable involving derivative liabilities into stock of $930,265, and the loss of $15,256 arising from the amendments of two notes payable with GHS, which eliminated the conversion features of both notes. During the six months ended December 31, 2016 there was no gain or loss on extinguishment of debt.

As of December 31, 2017, June 30, 2017, and June 30, 2016, the Company’s notes payable consists of the following:

On September 1, 2016, the Company purchased used office furniture and equipment from its landlord. The Company executed a note payable in the amount of $40,122 at an interest rate of 0% and with monthly payments of $1,115. The Company imputed interest on the note and recorded a discounted note balance of $36,634 on September 1, 2016. The term of the note is three years. The balance on the note was $19,936, $26,130, and $0 on December 31, 2017, June 30, 2017, and June 30, 2016, respectively. For the six months ended December 31, 2017 and 2016, interest expense on this note was $493 and $710, respectively. For the year ended June 30, 2017, interest expense on this note was $1,755.

On November 30, 2017 the Company amended two notes payable to GHS in the aggregate principal amount of $500,000. The notes, which were originally made on October 12 and November 2, 2017 and included conversion prices at 20% discount off market price, as defined in the agreements. The amendments removed the conversion features in the notes, totalling $500,000. Upon amendment, the Company recorded a loss on extinguishment of these notes of $15,256. As of December 31, 2017 the notes, which were previously included in Convertible Notes Payable are included in Notes Payable.

Notes Payable also includes two non-interest bearing notes totalling $30,000 that originated prior to the Company’s 2014 bankruptcy proceedings.

In June 2015, the Company entered into an exclusive manufacture and supply agreement with Rodney Peterson (an unrelated third party) or his designee, Rocky Mountain High Canada, Inc. (RMHC) for distribution rights to RMHC. Under the agreement, RMHC was required to pay the Company $500,000 before June 30, 2015 and submit an additional $150,000 prior to a production run of 1,000,000 cans of product covered under the agreement. The Company received $200,000 on July 29, 2015 and $300,000 on August 28, 2015, which was recorded as deferred revenue as of June 30, 2016. The additional $150,000 was not received. The Company filed a breach of contract lawsuit with the objective of recovering outstanding obligations. During the year ended June 30, 2017 the Company settled the case with RMHC and issued 6,800,000 shares of common stock in exchange for the $500,000 already received.

As of June 30, 2016 the Company has 800,000,000 shares of common stock authorized. On March 14, 2017 the Board of Directors and the holders of a majority of the voting capital stock of the Company increased this authorization to 950,000,000 and on September 19, 2017 the authorization was increased to 4,000,000,000 shares. As of December 31, 2017 there are 1,159,706,457 common shares issued and outstanding.

During the six months ended December 31, 2017 the Company issued 373,181,339 shares of common stock, including 321,291,865 for convertible notes payable conversions, 45,000,000 as part of a legal settlement, 789,474 for the conversion from Series E Preferred Shares, 5,600,000 for services rendered, and 500,000 for cash. During the six months ended December 31, 2016 the Company issued 197,090,550 shares of common stock for convertible notes payable conversions, warrant exercises, compensation, cash purchases, services rendered, and a legal settlement.

During the year ended June 30, 2017 the Company issued 248,535,354 shares of common stock, including 77,800,687 for convertible notes payable conversions, 46,908,834 for warrant exercises, 29,724,139 for services rendered, 21,634,107 for compensation, 6,800,000 as part of a legal settlement, and 65,667,587 for cash. During the year ended June 30, 2016 the Company issued 101,495,350 shares of common stock for convertible notes payable conversions, the acquisition of Dollar Shots Club, cash purchases, and services rendered.

On March 17, 2017, our Board of Directors approved the Rocky Mountain High Brands, Inc. 2017 Incentive Plan (the “2017 Incentive Plan”). The purpose of the Incentive Plan is to provide a means for the Company to continue to attract, motivate and retain management, key employees, consultants and other independent contractors, and to provide these individuals with greater incentive for their service to the Company by linking their interests in the Company’s success with those of the Company and its shareholders. Initially, the Board authorized 35,000,000 shares of the Company’s common stock to be included in the Plan. The Board of Directors awards these shares at its sole discretion.

On July 14, 2017 the Board of Directors increased the authorized shares in the 2017 Incentive Plan to 65,000,000.

On December 19, 2017 the Board of Directors increased the authorized shares in the 2017 Incentive Plan to 100,000,000.

As of December 31, 2017 the Company has 20,000,000 shares of Preferred Stock authorized and 10,789,474 designated through the various Series described below. The remaining 9,210,526 remain undesignated.

The Company has 1,000,000 shares of Series A Preferred Stock authorized and outstanding as of December 31, 2017 and June 30, 2017. LSW Holdings LLC (“LSW”), holds all of these shares. LSW’s Managing Member is Lily Li, RMHB’s Executive Vice President. In that capacity, Ms. Li has the authority to direct voting and investment decisions with regard to LSW’s interests in the Company.

On March 13, 2017, our Board of Directors approved a Certificate of Designation for our Series A Preferred Stock. This document revises and restates the rights, preferences and features of our Series A Preferred Stock, which consists of 1,000,000 shares, all of which are issued and outstanding. Holders of our Series A Preferred Stock were formerly entitled to cast 400 votes for every share held, and shares of Series A Preferred Stock were convertible to common stock at a rate of 100 shares of common stock for every share of Series A Preferred Stock. Following the filing of the Certificate of Designation, holders of Series A Preferred Stock are now entitled to cast 1,200 votes for every share held, and shares of Series A Convertible Preferred Stock are convertible to common stock at a rate of 1,200 shares of common stock for every share of Series A Preferred Stock.

On March 14, 2017, the board of directors and holders of a majority of the voting capital stock of the Company approved an amendment to the Company’s Articles of Incorporation to increase its authorized shares of preferred stock by 10,000,000. The Board of Directors fixed March 14, 2017 as the record date for determining the holders of its voting capital stock entitled to notice of these actions and receipt of this Information Statement. The increase in the authorization was effective in May 2017.

On July 5, 2017, the Company amended the Certificate of Designation for our Series A Preferred Stock. The amendment changed the conversion ratio of our Series A Preferred Stock from 1,200 shares of common stock for every share of Series A Preferred stock to 100 shares of common stock for every share of Series A Preferred Stock. The amendment was approved by the Company’s Board of Directors and LSW, the holder of our Series A Preferred Stock.

On July 24, 2017, the Company’s Board of Directors approved an amendment to the Certificate of Designation for the Series A Preferred Stock that changed the voting rights back to 400 votes from 1,200 for every share of Series A Preferred Stock.

The Series A Preferred Stock is the subject of the lawsuit filed by the Company,Rocky Mountain High Brands, Inc. f/k/a Republic of Texas Brands, Inc. Plaintiff, vs. Jerry Grisaffi, et al, which is disclosed in NOTE 18 – Legal Proceedings.

The Company has 5,000,000 shares of Series B Preferred Stock authorized and none outstanding as of December 31, 2017 and June 30, 2017.

The Company amended its Articles of Incorporation as of November 13, 2015 to authorize 2,000,000 shares of Series C Preferred Stock, which are 12% interest bearing, cumulative, exchangeable, non-voting, convertible preferred stock of the Company. Each Series C Preferred share is convertible 50 shares of common stock.

On November 16, 2015, the holder of a convertible note aggregating $1,107,607 of principal and accrued interest, agreed to a dollar for dollar exchange for same number of Series C Preferred Stock shares. As of June 30, 2017, there were 1,107,607 shares of Series C Preferred shares outstanding and the related redemption value of these shares was classified as a current liability. On October 6, 2017, the Company and the holder reached a legal settlement whereby the Company agreed to an exchange of the Preferred C Stock back to the originating note payable in accordance with the terms of the Exchange Agreement. The holder then assigned the note to GHS in exchange for $1,000,000 consideration paid to him by GHS. As of December 31, 2017, there are no Series C Preferred Stock shares outstanding.

The Company amended its Articles of Incorporation as of March 21, 2016 to authorize 2,000,000 shares of Series D Preferred Stock, a non-voting, non-interest bearing convertible preferred stock. Each Series C preferred share is convertible to 100 shares of common stock. As of December 31, 2017 and June 30, 2017, there are no Series D preferred shares outstanding.

On September 19, 2017, the Board of Directors approved a new Series E Preferred Stock. Holders of Series E Preferred Stock are entitled to cast 2,000 votes per share of Series E Preferred Stock on any proposal to increase our authorized capital stock, with no other voting rights. Series E Preferred Stock is convertible to common stock on a 1:1 basis. On the same day, the Board granted Michael Welch, Chairman of the Board 789,474 shares of Series E Preferred stock as payment for his deferred compensation. On October 31, 2017, Mr. Welch converted his 789,474 shares of Series E Preferred Stock to 789,474 shares of common stock. As of December 31, 2017, there are no shares of Series E Preferred Stock outstanding.

During the six months ended December 31, 2017, the Company granted no common stock warrants and none were exercised. As part of a legal settlement, 55,096,825 warrants were returned to the Company and cancelled on October 6, 2017. During the six months ended December 31, 2016, the Company granted 9,037,500 common stock warrants and 38,026,204 were exercised. As of December 31, 2017, June 30, 2017, and June 30, 2016, there are 650,000, 56,934,325, and 94,218,159 warrants outstanding respectively.

During the year ended June 30, 2017 the Company granted 9,725,000 warrants to purchase common stock and 47,008,834 were exercised. During the year ended June 30, 2016 the Company granted 39,000,000 warrants to purchase common stock and 3,658,914 were exercised.

During the six months ended December 31, 2017, the Company issued 39,440,000 options to purchase common stock. The options have an exercise price ranging from $.001 and $.003 and vested immediately. The Company recognized an expense of $203,045 at the grant dates as the options immediately vested. There were no options granted or outstanding during the six months ended December 31, 2016. As of December 31, 2017 and June 30, 2017, there are 67,790,000 and 28,350,000 options outstanding.

During the year ended June 30, 2017, the Company issued 27,000,000 options to purchase common stock to two new directors. The options have an exercise price ranging from $.035 and $.045 and vested immediately. The Company recognized $1,459,134 as compensation expense. The Company also granted 350,000 options to a vendor at an exercise price of $.045. None of these options had been exercised as of June 30, 2017. There were no options granted or outstanding during fiscal year 2016. The options were valued using the Black-Scholes model using an expected volatility of 114%, expected terms of 2 years, a risk-free interest rate of

During the six months ended December 31, 2017, the Company’s two largest customers each accounted for approximately 6% of sales. During the six months ended December 31, 2016, the Company’s two largest customers accounted for approximately 75% and 1% of sales, respectively.

During the year ended June 30, 2017, the Company’s two largest customers accounted for approximately 50% and 7% of sales, respectively. During the year ended June 30, 2016, the Company’s two largest customers accounted for approximately 27% and 26% of sales, respectively.

The reconciliation of income tax benefit at the U.S. statutory rate of 34% to the Company’s effective rate for the six months ended December 31, 2017 and 2016 and the years ended June 30, 2017 and 2016 is as follows:

The tax effects of temporary differences that give rise to the Company’s net deferred tax liability as of December 31, 2017, June 30, 2017 and June 30, 2016 consist of the following:

As of December 31, 2017, the Company had approximately $16,000,000 of federal and state net operating loss carryovers (“NOLs”), which begin to expire in 2028. Utilization of the NOLs may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under regulations.

The Company’s deferred tax assets and liabilities were remeasured to reflect the reduction in the U.S. corporate income tax rate from 34% to 21%, resulting in a deferred tax expense of approximately $2,000,000 for the six months ended December 31, 2017 that is still fully valued against as of December 31, 2017. This expense is attributable to the Company being in a net deferred tax asset position at the time of remeasurement. As the company maintains fully valuation allowance, this amount can be seen on the rate reconciliation as an adjustment to deferred tax asset and corresponding valuation allowance.

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) was signed into law making significant changes to the Internal Revenue Code. Changes include, but are not limited to, a federal corporate tax rate decrease from 35% to 21% for tax years beginning after December 31, 2017, the transition of U.S international taxation from a worldwide tax system to a territorial system, and a one-time transition tax on the mandatory deemed repatriation of foreign earnings. We have estimated our provision for income taxes in accordance with the Tax Act and guidance available as of the date of this filing but have kept the full valuation allowance. As a result have recorded no income tax expense during the six months ended December 31, 2017, the period in which the legislation was enacted.

The Company has a three-year lease for corporate office space. The lease commenced on September 1, 2016 with monthly payments of $7,715 in year one, $7,972 in year two, and $8,229 in year three. The lease is being accounted for on a straight-line basis over its term. The related straight-line rent liability is included in Accounts Payable and Accrued Liabilities.

On January 18, 2018, the RMHC entered into a 12-month office use agreement for office space in Denver, Colorado. Monthly payments are $91.

The Company rents storage space from various third parties on a month-to-month basis.

The Company has entered into employment agreements with the following Board members and officers:

Arbitration Claim of Roy J. Meadows Against Rocky Mountain High Brands, Inc. dated February 24, 2016

On October 6, 2017 the Company executed a Release and Settlement Agreement with Roy Meadows (“Meadows Settlement”) regarding the litigation between the parties. As part of the Meadows Settlement, the Company agreed to issue 45 million shares of the Company’s common stock, including 20 million shares issued immediately and 25 million shares to be issued upon the effectiveness of the Company’s increased common share authorization, which occurred on October 31, 2017. Mr. Meadows is subject to a “leak-out” formula whereby he is limited in the number of shares he can re-sell if the stock price is below $.06 per share. In connection with this settlement, the Company agreed to an exchange of the Preferred C Stock back to the originating note payable in accordance with the terms of the Exchange Agreement. Mr. Meadows assigned the note to GHS Investments, LLC, (“GHS”) an outside investment group, in exchange for $1,000,000 in consideration paid to him by GHS. Mr. Meadows released the Company from all claims and returned 55,096,825 stock warrants.

On October 6, 2017 the Company executed a Release and Settlement Agreement with Donna Rayburn regarding the litigation between the Company and Ms. Rayburn. Ms. Rayburn released the Company from all claims and returned 10 million stock warrants.

Rocky Mountain High Brands, Inc. v Lyonpride Music, LLC, United States District Court Northern District of Texas, 3:18-cv-00045-C

Los Angeles Superior Court, BC669367, filed July 24, 2017. Statewide Beverage Company, Inc. v. Rocky Mountain High Brands, Inc.

The Company is seeking the return of Series A Preferred Stock and common stock issued to certain defendants or later obtained by certain other defendants for little or no consideration paid to the Company. The Company alleges that RMHB’s former Chairman of the Board breached his fiduciary duty to the Company by issuing these shares to himself and others. RMHB is also seeking to void the Indemnification and Release Agreement between the parties that was executed in June 2017. The Company is awaiting response from discovery requests at the current time. A trial date has been set for December 2018.

Between January 1 and March 30, 2018, the Company issued 349,469,321 shares of common stock, including 168,805,244 for convertible notes payable conversions, 10,597,405 for director and employee compensation, 29,096,402 for option exercises, 5,821,256 for services rendered, and 135,149,014 for proceeds of $1,293,600.

Between January 1 and March 30, 2018, the Company issued convertible notes payable in the amount of $300,000 and amended two notes payable to GHS in the aggregate amount of $500,000 to include a conversion feature of $.005. Holders of convertible notes payable converted $308,727 of outstanding principal during that same period.

On January 5, 2018 the Company entered into a $300,000 secured convertible promissory note with GHS. On January 9, 2018 the Company amended two $250,000 secured promissory notes payablewith GHS to include a $.005 conversion feature.

On February 9, 2018 the Company received a notice of effectiveness from the Securities and Exchange Commission on its Registration Statement on Form S-1/A. The registration statement registered 250,000,000 shares of common stock for resale by GHS. Subsequent to the effective date, the Company sold 94,826,433 shares of stock to GHS in accordance with the EFA.

The following table sets forth all expenses to be paid by the Registrant, other than estimated placement agents’ fees and commissions, in connection with our public offering. All amounts shown are estimates except for the SEC registration fee:

SEC registration fee	$	422.31
Legal fees and expenses		15,000
Accounting fees and expenses		2,000
Transfer agent and registrar fees		-
Printing and engraving expenses		-
Miscellaneous fees and expenses		-
Total	$	17,422.31

NRS 78.7502(1) provides that a corporation may indemnify any personwho was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.

NRS Section 78.7502(2) provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there from, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

NRS Section 78.747 provides that except as otherwise provided by specific statute, no director or officer of a corporation is individually liable for a debt or liability of the corporation, unless the director or officer acts as the alter ego of the corporation. The court as a matter of law must determine the question of whether a director or officer acts as the alter ego of a corporation.

Our charter provides that we will indemnify our directors, officers, employees and agents to the extent and in the manner permitted by the provisions of the NRS, as amended from time to time, subject to any permissible expansion or limitation of such indemnification, as may be set forth in any stockholders’ or directors’ resolution or by contract. Any repeal or modification of these provisions approved by our stockholders will be prospective only and will not adversely affect any limitation on the liability of any of our directors or officers existing as of the time of such repeal or modification. We are also permitted to apply for insurance on behalf of any director, officer, employee or other agent for liability arising out of his actions, whether or not the NRS would permit indemnification.

Our bylaws provide that a director or officer of the Company shall have no personal liability to the Company or its stockholders for damages for breach of fiduciary duty as a director or officer, except for damages for breach of fiduciary duty resultinofficer, employee or other agent for liability arising out of his actions, whether or not the NRS would permit indemnification.g from (a) acts or omissions which involve intentional misconduct, fraud, or a knowing violation of law, or (b) the payment of dividends in violation of section 78.3900 of the NRS as it may from time to time be amended or any successor provision thereto.

⁽¹⁾Incorporated by reference to Registration Statement on Form 10 filed June 22, 2016.

⁽²⁾ Incorporated by reference to Amended Registration Statement on Form 10 filed September 29, 2016.

⁽³⁾Incorporated by reference to Current Report on Form 8-K filed March 15, 2017.

⁽⁴⁾Incorporated by reference to Current Report on Form 8-K filed April 3, 2017.

⁽⁵⁾Incorporated by reference to Current Report on Form 8-K filed May 12, 2017.

⁽⁶⁾Incorporated by reference to Current Report on Form 8-K filed July 6, 2017.

⁽⁷⁾Incorporated by reference to Current Report on Form 8-K filed July 14, 2017.

⁽⁸⁾Incorporated by reference to Current Report on Form 8-K filed September 21, 2017.

⁽¹⁰⁾Incorporated by reference to Current Report on Form 8-K filed October 12, 2017

⁽¹¹⁾Incorporated by reference to Current Report on Form 8-K filed October 16, 2017

⁽¹²⁾Incorporated by reference to Registration Statement on Form S-1 filed November 1, 2017.

⁽¹³⁾Incorporated by reference to Registration Statement on Form S-1/A filed December 7, 2017.

⁽¹⁴⁾Incorporated by reference to Registration Statement on Form S-1/A filed January 16, 2018.

⁽¹⁵⁾Incorporated by reference to Registration Statement on Form S-1 filed July 6, 2018

⁽¹⁶⁾Incorporated by reference to Current Report on Form S-8 filed July 27, 2018

⁽¹⁷⁾ Incorporated by reference to Registration Statement on Form S-1/A filed August 8, 2018.

⁽¹⁸⁾ Incorporated by reference to Registration Statement on Form S-1/A filed September 7, 2018

The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.

In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

For the purpose of whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A(§230.430A of this chapter), shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this registration statement on Form S-1/A to be signed on its behalf by the undersigned, thereunto duly authorized, in Dallas, Texas, on the ~~7thday~~9th day of ~~September,~~October 2018.

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael Welch his true and lawful attorney-in-fact and agent with full power of substitution and re-substitution, for him/her and in his name, place and stead, in any and all capacities to sign any or all amendments (including, without limitation, post-effective amendments) to this Registration Statement, any related Registration Statement filed pursuant to Rule 462(b) under the Securities Act of 1933 and any or all pre- or post-effective amendments thereto, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that said attorney-in-fact and agent, or any substitute or substitutes for him, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, the following persons in the capacities and on the dates indicated have signed this Registration Statement below.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

Nevada	2080	90-0895673
(State or other jurisdiction	(Primary Standard Industrial	(I.R.S. Employer
of incorporation or organization)	Classification Code Number)	Identification Number)

Name of Selling Shareholder	Shares Owned Prior to this Offering⁽¹⁾	Total Number of Shares to be Offered for Selling Shareholder Account	Total Shares to be Owned Upon Completion of this Offering	Percent Owned Upon Completion of this Offering
GHS Investments, LLC⁽²⁾	21,338,199	333,056,161	8,282,038	0.51%

Name of Selling Shareholder	Shares Owned Prior to this Offering⁽¹⁾	Total Number of Shares to be Offered for Selling Shareholder Account	Total Shares to be Owned Upon Completion of this Offering	Percent Owned Upon Completion of this Offering
GHS Investments, LLC⁽²⁾	11,283,410⁽³⁾	320,000,000	11,283,410	0.66%

Balance, June 30, 2015	$	11,504,057
Issued during the year ended June 30, 2016		3,887,618
Converted during the year ended June 30, 2016		(2,102,681)
Change in fair value recognized in operations		(11,071,250)
Balance, June 30, 2016		2,217,744
Issued during the year ended June 30, 2017		1,383,650
Exercises/Conversions		(479,834)
Change in fair value recognized in operations		1,951,019
Balance, June 30, 2017		5,072,579
Issued during the six months ended December 31, 2017		4,017,623
Converted during the six months ended December 31, 2017		(5,276,018)
Change in fair value recognized in operations		1,795,205
Balance, December 31, 2017	$	5,609,389

	December 31, 2017		June 30, 2017			June 30, 2016
Estimated dividends		None		None			None
Expected volatility		165		114	%		45%
Risk free interest rate		1.39		.84	%		.12%
Expected term		.1 to 4.8 years		1 to 2.0 years			1 to 5.5 years

	Page
Prospectus Summary	5
Risk Factors	9
Cautionary Note Regarding Forward-Looking Statements and Industry Data	15
Selling Stockholder	15
Price Range of Common Stock and Related Matters	16
Dividend Policy	18
Dilution	18
Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Business	30
Management	35
Security Ownership of Certain Beneficial Owners and Management	45
Certain Relationships and Related Party Transactions	46
Description of Securities	47
Plan of Distribution	49
Legal Matters	50
Experts	50
Where You Can Find More Information	50
Index to Financial Statements	50

Lease Period	Base Rent (monthly)
9/1/2016 to 8/31/2017	$	7,715.00
9/1/2017 to 8/31/2018	$	7,972.17
9/1/2018 to 8/31/2019	$	8,229.33

NAME	AGE	POSITION
Michael Welch	64	Chairman of the Board, President and Chief Executive Officer

Jens Mielke	51	Chief Financial Officer

David Seeberger	62	Director and Vice President, Legal

Charles Smith	61	Director and Chief Operating Officer

John Blackington	65	Chief Commercialization Officer

Winton Morrison	80	Director

Dean Blythe	59	Director

Name and Principal Position	Year		Salary		Bonus		Stock Awards		Warrant Awards		Non-Equity Incentive Plan Compensation		Non-Qualified Deferred Compensation Earnings		All Other Compensation		Total
Michael Welch, President and CEO (1)		2017	$	75,000	$	—	$	—	$	36,166	$	—	$	—	$	—	$	111,166
		2016		75,000		—		26,274		—		—		—		—	$	101,274
Jens Mielke, Chief Financial Officer (2)		2017		65,000		—		—		25,833		—		—		—	$	90,833
		2016		60,000		—		24,360		—		—		—		—	$	84,360
Charles Smith, Chief Operating Officer (3)		2017		30,000		—		—		18,083		—		—		—	$	48,083
		2016		—		—		87,000		—		—		—		—	$	87,000
David Seeberger, Vice President Legal (4)		2017		60,000		—		—		42,980		—		—		—	$	127,340
		2016		60,000		—		—		24,360		—		—		—	$	84,360
Lily Li, Vice President of International Sales (5)		2017		—		—		—		—		—		—		—	$	—
		2016		—		—		—		—		—		—		—	$	—
Jerry Grisaffi, Founder, Former Secretary and Former Chairman of the Board (6)		2017		—		—		—		—		—		—		—	$	—
		2016		12,946		—		131,187		—		—		—		—	$	144,133
John Blackington, Chief Commercialization Officer(7)		2017		—		—		—		36,166		—		—		—	$	36,166
		2016		—		—		—		—		—		—		—	$	—

Name	Number of Securities Underlying Unexercised Options/Warrants (#) Exercisable (1)		Number of Securities Underlying Unexercised Options/Warrants (#) Unexercisable		Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options/Warrants (#)		Option/Warrant Exercise Price ($)		Option/Warrant Expiration Date	Number of Shares or Units of Stock That Have Not Vested (#)		Market Value of Shares or Units of Stock That Have Not Vested ($)		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)		Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (#)
Michael Welch, President and CEO		7,000,000		—		—	$	0.003	12/19/2019		—		—		—		—
Jens Mielke, Chief Financial Officer		5,000,000						0.003	12/19/2019
Charles Smith, Chief Operating Officer		3,500,000						0.003	12/19/2019
David Seeberger, Vice President and General Counsel		8,000,000						0.003	12/19/2019
John Blackington, Chief Commercialization Officer		7,000,000						0.003	12/19/2019

Name	Fees Earned or Paid in Cash		Stock Awards		Option Awards		Non-Equity Incentive Plan Compensation		Non-Qualified Deferred Compensation Earnings		All Other Compensation		Total
Michael Welch (1)	$	87,000	$	—	$	—	$	—	$	—	$	—	$	87,000
Charles Smith (2)		—		—		—		—		—		—	$	—
David Seeberger (3)		—		—		—		—		—		—	$	—
Winton Morrison (2)		—		18,083		—		—		—		—	$	18,083
Gerry David (4)		24,000		—		—		—		—		—	$	24,000
Kevin Harrington (4)		24,000		—		—		—		—		—	$	24,000

F-1	Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 (unaudited);
F-2	Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 (unaudited);
F-3	Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited);
F-4	Notes to Consolidated Financial Statements (unaudited).

F-12	Report of Paritz & Company, P.A., Independent Registered Public Accounting Firm
F-13	Consolidated Balance Sheets as of December 31, 2017, June 30, 2017, and June 30, 2016
F-14	Consolidated Statements of Operations for the six months ended December 31, 2017 and 2016 and the years ended June 30, 2017 and 2016
F-15	Consolidated Statements of Cash Flows for the six months ended December 31, 2017 and 2016 and the years ended June 30, 2017 and 2016
F-16	Consolidated Statements of Shareholder’s Deficit for thesix months ended December 31, 2017 and 2016 and the years ended June 30, 2017 and 2016
F-17	Notes to Consolidated Financial Statements.

	June 30, 2018			December 31, 2017

CURRENT ASSETS
Cash	$	325,158		$	16,983
Accounts Receivable, net of allowance of $196,701 and $195,632		21,517			2,844
Inventory		77,390			82,312
Prepaid Expenses and Other Current Assets		556,282			634,722
TOTAL CURRENT ASSETS		980,347			736,861
Property and Equipment, net		36,516			35,681
Other Assets		40,211			29,093

TOTAL ASSETS	$	1,057,074		$	801,635

LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES

Accounts Payable and Accrued Liabilities	$	406,113		$	750,807
Related Party Convertible Notes Payable, net of debt discount		—			174,456
Convertible Notes Payable, net of debt discount		1,083,397			677,698
Notes Payable		43,808			549,936
Accrued Interest		50,389			81,248
Derivative Liability		599,424			5,609,389
TOTAL CURRENT LIABILITIES		2,183,131			7,843,534
SHAREHOLDERS' DEFICIT
Preferred Stock - Series A - Par Value of $.001; 1,000,000 shares designated; 1,000,000 shares issued and outstanding as of June 30, 2018 and December 31, 2017		1,000			1,000
Preferred Stock - Series B - Par Value of $.001; 7,000,000 shares designated; No shares issued and outstanding		—			—
Preferred Stock - Series C - Par Value of $.001; 2,000,000 shares designated; No shares issued and outstanding		—			—
Preferred Stock - Series D - Par Value of $.001; 2,000,000 shares designated; No shares issued and outstanding		—			—
Preferred Stock - Series E - Par Value of $.001; 789,474 shares designated; No shares issued and outstanding		—			—
Common Stock - Par Value of $.001; 4,000,000,000 shares authorized; 1,630,599,328 shares issued and outstanding as of June 30, 2018; 1,159,706,457 shares issued and outstanding as of December 31, 2017		1,630,599			1,159,706
Additional Paid-In Capital		32,614,617			23,459,809
Accumulated Deficit		(35,372,273	)		(31,662,414	)
TOTAL SHAREHOLDERS’ DEFICIT		(1,126,057	)		(7,041,899	)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$	1,057,074		$	801,635

	Three Months Ended						Six Months Ended
	June 30, 2018			June 30, 2017			June 30, 2018			June 30, 2017

Sales, net of returns	$	72,675		$	(36,178	)	$	123,584		$	81,636

Cost of Sales		97,800			(4,552	)		164,790			52,283
Inventory Obsolescence		11,424			72,161			11,424			72,161

Gross Profit (Loss)		(36,549	)		(103,787	)		(52,630	)		(42,808)

Operating Expenses
General and Administrative		909,788			2,650,173			1,990,306			3,898,375
Advertising and Marketing		211,295			79,967			281,117			764,574
Total Operating Expenses		1,121,083			2,730,140			2,271,423			4,662,949

Loss from Operations		(1,157,632	)		(2,833,927	)		(2,324,053	)		(4,705,757)

Other (Income)/Expenses:
Interest Expense		365,570			512,732			3,182,698			645,783
(Gain) Loss on Extinguishment of Debt		(5,362	)		—			191,138			—
Gain on Change in Redemption Value of Series C Preferred Stock		—			(834,242	)		—			(834,242)
(Gain) Loss on Change in Fair Value of Derivative Liability		(140,045	)		(846,179	)		(1,988,030	)		1,618,260
Total Other (Income) Expenses:		220,163			(1,167,689	)		1,385,806			1,429,801

Loss Before Income Tax Provision		(1,377,795	)		(1,666,238	)		(3,709,859	)		(6,135,558)

Income Tax Provision		—			—			—			—

Net Loss	$	(1,377,795	)	$	(1,666,238	)	$	(3,709,859	)	$	(6,135,558)

Net Loss per Common Share - Basic and Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01)

Weighted Average Shares Outstanding		1,570,535,052			785,030,105			1,469,492,864			770,891,786

	Six Months Ended
	June 30,2018			June 30, 2017
Operating Activities:
Net Loss	$	(3,709,859	)	$	(6,135,558)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation		319,143			1,508,097
Stock-based payments to vendors		65,250			548,084
Warrants and options issued for services rendered		44,476			1,666,781
Non-cash interest expense		3,057,912			645,782
Fees and penalties on debt		120,251			—
Gain on change in redemption value of Series C Preferred Stock		—			(834,242)
(Gain) Loss on change in fair value of derivative liability		(1,988,030	)		1,618,260
Loss on extinguishment of debt		191,138			—
Loss on disposal of property and equipment		—			15,912
Bad debt expense		1,069			184,966
Depreciation and amortization expense		12,732			12,095
Inventory obsolescence		11,424			72,161
Changes in operating assets and liabilities:
Accounts Receivable		(19,742	)		14,195
Inventory		(6,502	)		(78,585)
Prepaid expenses		(57,210	)		(173,436)
Other assets		17,500			3,431
Accounts payable and accrued liabilities		(344,694	)		(180,931)
NET CASH USED IN OPERATING ACTIVITIES		(2,285,142	)		(1,112,988)
Investing Activities:
Investment in other assets		(31,220	)		(4,252)
Acquisition of property and equipment		(10,965	)		(9,209)
NET CASH USED IN INVESTING ACTIVITIES		(42,185	)		(13,461)
Financing Activities:

Proceeds from issuance of convertible notes		300,000			370,000
Repayment of convertible notes		(172,932	)		—
Proceeds from issuance of related party convertible notes		—			189,000
Repayment of related party convertible notes		—			(25,000)
Repayment of notes payable		(6,128	)		(5,637)
Proceeds from issuance of common stock		2,514,562			534,700
NET CASH PROVIDED BY FINANCING ACTIVITIES		2,635,502			1,063,063
INCREASE (DECREASE) IN CASH		308,175			(63,386)
CASH - BEGINNING OF PERIOD		16,983			155,061

CASH - END OF PERIOD	$	325,158		$	91,675

Supplemental disclosure of non-cash financing and investing activities:
Common stock issued for conversion of debt	$	3,489,181		$	1,432
Debt and accrued interest converted for common stock	$	499,053		$	62,103
Derivative liability incurred for debt discount	$	—		$	659,150
Derivative liability relieved upon conversion of related debt	$	3,021,935		$	34,500
Beneficial conversion feature recognized	$	3,328,740		$	348,532

Balance, December 31, 2017	$	5,609,389
Issued during the six months ended June 30, 2018	$
Exercises/Conversions	$	(3,021,935)
Change in fair value recognized in operations	$	(1,988,030)
Balance, June 30, 2018	$	599,424

	June 30, 2018		December 31, 2017
Finished inventory	$	71,205	$	77,517
Raw materials and packaging		6,185		4,795
Total	$	77,390	$	82,312

		June 30, 2018		December 31, 2017
Prepaid officers’ compensation	$	368,383	$	445,149
Prepaid directors’ compensation		88,324		147,207
Prepaid marketing expenses		8,250		13,750
Note receivable		80,000		—
Other prepaid expenses and current assets		11,325		28,616
Total	$	556,282	$	634,722

	June 30, 2018		December 31, 2017
Vehicles	$	29,598	$	29,598
Furniture and equipment		45,322		42,538
Personal computers		10,559		2,379
		85,479		74,515
Less: accumulated depreciation		48,963		38,834
Total	$	36,516	$	35,681

	June 30, 2018		December 31, 2017
Accounts payable	$	265,982	$	373,882
Accrued compensation		22,500		215,026
Other accrued expenses		117,631		161,899
Total	$	406,113	$	750,807

	Interest Rates		Term		June 30,2018			December 31,2017
Convertible Notes Payable		6% - 10%		0 - 8months	$	1,336,101		$	1,026,995
Discount						(252,704	)		(349,297)
Total					$	1,083,397		$	677,698

	Interest Rate		Term		June30, 2018		December 31, 2017
Related party convertible notes payable		6%		0 years	$	—	$	179,000
Discount								(4,544)
Total					$	—	$	174,456

		June 30, 2018		December 31, 2017
Deferred Tax Assets
Net Operating Losses	$	3,800,000	$	3,360,000
Less: Valuation Allowance	$	(3,800,000)	$	(3,360,000)
Deferred Tax Assets – Net		—		—

/s/ Paritz & Company, P.A.

We have served as the Company’s auditor since 2015.

Hackensack, New Jersey
April 2, 2018

	Six Months Ended						Year Ended
	December 31, 2017			December 31, 2016 (Unaudited)			June 30, 2017			June 30, 2016

Sales	$	59,653		$	320,338		$	401,974		$	1,075,476

Cost of Sales		79,933			98,639			150,922			408,918
Inventory Obsolescence		93,110			28,837			100,998			725,718

Gross Profit (Loss)		(113,390	)		192,862			150,054			(59,160)

Operating Expenses
General and Administrative		2,567,486			1,853,089			5,751,464			2,142,984
Advertising and Marketing		118,191			749,059			1,513,633			1,340,428
Impairment Expense		59,163			—			—			166,000
Total Operating Expenses		2,744,840			2,602,148			7,265,097			3,649,412

Loss from Operations		(2,858,230	)		(2,409,286	)		(7,115,043	)		(3,708,572)

Other (Income)/Expenses:
Interest Expense		2,054,438			398,648			1,044,431			203,496
Debt Inducement Expense		—			—			—			3,887,618
Loss (Gain) on Extinguishment of Debt		(1,200,092	)		—			—			945,838
Gain on Redemption Value of Series C Preferred Stock		—			—			(834,242	)		—
Loss (Gain) on Change in Fair Value of Derivative Liability		1,795,205			332,759			1,951,019			(11,071,250)
Total Other (Income) Expenses:		2,649,551			731,407			2,161,208			(6,034,298)

Income (Loss) Before Income Tax Provision		(5,507,781	)		(3,140,693	)		(9,276,251	)		2,325,726

Income Tax Provision		—			—			—			—

Net Income (Loss)	$	(5,507,781	)	$	(3,140,693	)	$	(9,276,251	)	$	2,325,726

Net Income (Loss) per Common Share - Basic and Diluted	$	(0.01	)	$	(0.00	)	$	(0.01	)	$	0.01

Weighted Average Shares Outstanding		855,469,994			629,289,895			699,508,915			474,571,836

	Common Stock				Preferred Stock A				Preferred Stock C				Preferred Stock E								Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		Shares			Amount			Additional Paid-In Capital		Deficit			Total

Balance - June 30, 2017		786,525,118	$	786,525		1,000,000	$	1,000		—	$	—		—		$	—		$	18,062,830	$	(26,154,633	)	$	(7,304,278	)

Shares issued for cash		500,000		500																8,000					8,500

Shares issued for compensation														789,474			789			14,211					15,000

Preferred shares converted to common shares		789,474		789										(789,474	)		(789	)							—

Stock options issued to Board members and employees																				179,116					179,116

Shares issued upon conversion of convertible notes		321,291,865		321,292																3,626,114					3,947,406

Stock options issued for services rendered		5,600,000		5,600																174,563					180,163

Shares issued as part of a legal settlement		45,000,000		45,000																1,394,975					1,439,975

Net loss for the six months ended December 31, 2017		—		—		—		—		—		—		—			—			—		(5,507,781	)		(5,507,781	)

Balance - December 31, 2017		1,159,706,457	$	1,159,706		1,000,000	$	1,000		—	$	—		—		$	—		$	23,459,809	$	(31,662,414	)	$	(7,041,899	)

	December 31, 2017		June 30, 2017		June 30, 2016
Finished inventory	$	77,517	$	216,711	$	290,368
Raw materials and packaging		4,795		7,984		—
Total	$	82,312	$	224,695	$	290,368

	Interest Rates	Term		December 31, 2017			June 30, 2017			June 30, 2016
Convertible notes payable	6% - 10%		0 - 2 years	$	1,026,995		$	1,115,000		$	597,500
Discount					(349,297	)		(381,747	)		—
Total				$	677,698		$	733,253		$	597,500

	Six Months Ended December 31, 2017	Six Months Ended December 31, 2016	Year Ended June 30, 2017	Year Ended June 30, 2016
U.S federal statutory rate	(34%)	(34%)	(34%)	(34%)
State income tax, net of federal benefit	(0.0%)	(0.0%)	(0.0%)	(0.0%)
Increase in valuation allowance	34%	34%	34%	34%
Income tax provision (benefit)	0.0%	0.0%	0.0%	0.0%

Date	Name	Shares	Price	Description		Exemption
1/3/2017	Louis G. Walz	588,236	0.0170	Shares Sold		Rule 506
1/3/2017	Ruth Kerico	500,000	0.0200	Shares Sold		Rule 506
1/3/2017	Bruce Wunsch	100,000	0.0170	Services Rendered		Section 4(2)
1/3/2017	Eagle Manufacturing Solutions	491,176	0.0170	Services Rendered		Section 4(2)
1/3/2017	Patricia Ann Wright	150,000	0.0170	Services Rendered		Section 4(2)
1/3/2017	Eason Wright	500,000	0.0170	Services Rendered		Section 4(2)
1/3/2017	John Jay Saldi	100,000	0.0170	Services Rendered		Section 4(2)
1/3/2017	Earl Pontillo	250,000	0.0200	Shares Sold		Rule 506
1/3/2017	Ann M. Wieringa	900,000	0.0170	Shares Sold		Rule 506
1/4/2017	Ann M. Wieringa	900,000	0.0170	Shares Sold		Rule 506
1/4/2017	Vista Capital Investments	10,000,000	0.0200	Shares Sold		Rule 506
1/6/2017	Eagle Manufacturing Solutions	1,588,236	0.0170	Shares Sold		Rule 506
1/6/2017	Leroy Wheeler	185,185	0.0270	Shares Sold		Rule 506
1/6/2017	David Economon	200,000	0.0170	Shares Sold		Rule 506
1/6/2017	Robert & Kimberly Payne	200,000	0.0250	Shares Sold		Rule 506
1/6/2017	Tammie L. Borders	200,000	0.0250	Shares Sold		Rule 506
1/6/2017	Fred and Linda Borders	600,000	0.0250	Shares Sold		Rule 506
1/12/2017	ValueCorp Trading Company	1,000,000	0.0200	Shares Sold		Rule 506
1/17/2017	John R Anderson	166,667	0.0300	Shares Sold		Rule 506
1/17/2017	Muleshoe Ranch	166,667	0.0300	Shares Sold		Rule 506
1/17/2017	Steve Gill (Shelving Exchange)	166,667	0.0300	Shares Sold		Rule 506
1/18/2017	David Economon	350,000	0.0200	Shares Sold		Rule 506
1/20/2017	Howard Bruckner	200,000	0.0500	Shares Sold		Rule 506
1/20/2017	Brooks Goodson	300,000	0.0500	Shares Sold		Rule 506
1/20/2017	Robert & Kimberly Payne	100,000	0.0500	Shares Sold		Rule 506
1/23/2017	Ronnie Neu	555,556	0.0270	Shares Sold		Rule 506
1/23/2017	Patricia Ann Wright	285,714	0.0350	Shares Sold		Rule 506
1/23/2017	Crackerjack Classic LLC	1,500,000	0.0010	Exercise of Warrants		Rule 506
1/24/2017	Arthur Rezac	100,000	0.0500	Shares Sold		Rule 506
1/27/2017	Patrick Dennehy	100,000	0.0500	Shares Sold		Rule 506
2/1/2017	William Penz	200,000	0.0500	Shares Sold		Rule 506
2/15/2017	Yael Moyal	2,571,429	0.0350	Shares Sold		Rule 506
2/17/2017	Richard B Main	222,222	0.0450	Shares Sold		Rule 506
2/22/2017	Lily Li	10,000,000	0.1150	Services Rendered		Section 4(2)
2/24/2017	Thomas O. Layman	200,000	0.0500	Shares Sold		Rule 506
2/27/2017	Allred, Wilcox, & Hartley PLLC	181,600	0.0840	Services Rendered		Section 4(2)
2/27/2017	Yeal Moyal	1,285,714	0.0350	Shares Sold		Rule 506
2/27/2017	Kathy Fernandez	100,000	0.0200	Shares Sold		Rule 506
2/27/2017	Mark Ussery	100,000	0.1100	Services Rendered		Section 4(2)
2/27/2017	Terry Niedecken	100,000	0.1100	Services Rendered		Section 4(2)
3/1/2017	Kathy Fernandez	505,096	0.0100	Note Payable Conversion		Rule 506
3/27/2017	EPIC Group One	11,000,000	0.0850	Services Rendered		Section 4(2)
3/31/2017	Jens Mielke	357,143	0.0420	Services Rendered		Section 4(2)
3/31/2017	Michael Welch	206,044	0.0420	Services Rendered		Section 4(2)
3/31/2017	David Seeberger	137,363	0.0420	Services Rendered		Section 4(2)
4/7/2017	Small Cap Voice	300,000	0.0877	Services Rendered		Section 4(2)
6/29/2017	Morris Rafi	1,534,089	0.0349	Note Payable Conversion		Rule 506
8/23/2017	Universal Consulting LLC	3,147,288	0.0100	Note Payable Conversion		Rule 506
9/15/2017	Homie Doroodian	3,093,640	0.0177	Note Payable Conversion		Rule 506
10/13/2017	GHS Investments LLC	24,000,000	0.0108	Note Payable Conversion		Rule 506
10/18/2017	Roy Meadows	20,000,000	0.0216	Note Payable Conversion		Rule 506
10/31/2017	Michael Welch	789,474	0.0196	Services Rendered		Section 4(2)
11/1/2017	Roy Meadows	25,000,000	0.0201	Note Payable Conversion		Rule 506
11/3/2017	Metexas Georgatos	750,000	0.0186	Services Rendered		Section 4(2)
11/3/2017	Eduardo Cabrera	2,250,000	0.0186	Services Rendered		Section 4(2)
11/3/2017	Wellington Shields Holdings LLC	2,000,000	0.0186	Services Rendered		Section 4(2)
11/6/2017	Small Cap Voice	600,000	0.0168	Services Rendered		Section 4(2)
11/9/2017	GHS Investments LLC	28,000,000	0.0162	Note Payable Conversion		Rule 506
11/13/2017	Vista Capital Investments, LLC	3,703,704	0.007		Note Payable Conversion	Rule 506
11/20/2017	Vista Capital Investments, LLC	9,345,794	0.005		Note Payable Conversion	Rule 506
11/27/2017	Homie Doroodian	11,634,639	0.005		Note Payable Conversion	Rule 506
11/27/2017	Vista Capital Investments, LLC	12,987,013	0.004		Note Payable Conversion	Rule 506
11/30/2017	GHS Investments	12,000,000	0.004		Note Payable Conversion	Rule 506
12/4/2017	Vista Capital Investments, LLC	17,857,143	0.003		Note Payable Conversion	Rule 506
12/5/2017	GHS Investments	15,000,000	0.004		Note Payable Conversion	Rule 506
12/5/2017	GHS Investments	30,000,000	0.004		Note Payable Conversion	Rule 506
12/12/2017	Vista Capital Investments, LLC	17,857,143	0.003		Note Payable Conversion	Rule 506
12/13/2017	GHS Investments	23,000,000	0.004		Note Payable Conversion	Rule 506
12/19/2017	GHS Investments	44,740,000	0.003		Note Payable Conversion	Rule 506
12/19/2017	Vista Capital Investments, LLC	18,867,925	0.003		Note Payable Conversion	Rule 506
12/26/2017	GHS Investments	46,057,576	0.003		Note Payable Conversion	Rule 506
1/2/2017	GHS Investments	27,000,000	0.003		Note Payable Conversion	Rule 506
1/2/2018	Vista Capital Investments, LLC	18,867,925	0.003		Note Payable Conversion	Rule 506
1/3/2018	GHS Investments	18,700,000	0.003		Note Payable Conversion	Rule 506
1/4/2018	GHS Investments	14,285,715	0.004		Note Payable Conversion	Rule 506
1/9/2018	Vista Capital Investments, LLC	15,094,340	0.003		Note Payable Conversion	Rule 506
1/9/2018	Eagle Equities LLC	20,062,924	0.003		Note Payable Conversion	Rule 506
1/16/2018	GHS Investments	35,500,000	0.003		Note Payable Conversion	Rule 506
1/18/2018	GHS Investments	4,200,000	0.004		Note Payable Conversion	Rule 506
1/19/2018	Vista Capital Investments, LLC	15,094,340	0.003		Note Payable Conversion	Rule 506
1/24/2018	John Blackington	5,489,209	0.003		Option Exercise	Section 4(2)
1/24/2018	Jens Mielke	5,000,000	0.003		Option Exercise	Section 4(2)
1/24/2018	David Seeberger	6,000,000	0.003		Option Exercise	Section 4(2)
1/24/2018	David Seeberger	2,000,000	0.003		Option Exercise	Section 4(2)
1/24/2018	Chuck Smith	2,744,604	0.003		Option Exercise	Section 4(2)
1/24/2018	Michael Welch	7,000,000	0.003		Option Exercise	Section 4(2)
1/24/2018	Christian Vega	588,129	0.003		Option Exercise	Section 4(2)
1/24/2018	Kathy Fernandez	274,460	0.003		Option Exercise	Section 4(2)
2/9/2018	Michael Welch	2,188,334	0.012		Services Rendered	Section 4(2)
2/9/2018	Chuck Smith	3,333,334	0.012		Services Rendered	Section 4(2)
2/9/2018	David Seeberger	2,416,167	0.012		Services Rendered	Section 4(2)
2/9/2018	Winton Morrison	166,667	0.012		Services Rendered	Section 4(2)
2/9/2018	Jens Mielke	2,492,903	0.012		Services Rendered	Section 4(2)
2/13/2018	GHS Investments	34,482,759	0.012		Shares Sold	Rule 506
2/28/2018	GHS Investments	32,679,739	0.012		Shares Sold	Rule 506
3/5/2018	Quartz Concepts	289,855	0.010		Services Rendered	Section 4(2)
3/5/2018	Tom Blackington	120,773	0.010		Services Rendered	Section 4(2)
3/5/2018	Harrington Business Development	2,705,314	0.010		Services Rendered	Section 4(2)
3/5/2018	Gerry David	2,705,314	0.010		Services Rendered	Section 4(2)
3/19/2018	GHS Investments	27,663,935	0.010		Shares Sold	Rule 506
3/29/2018	GHS Investments	40,322,581	0.010		Shares Sold	Rule 506
3/30/2018	GHS Investments	40,322,581	0.0099	Shares Sold		Rule 506
3/31/2018	Tom Blackington	104,167	0.0120	Services Rendered		Section 4(2)
4/2/2018	Dean Blythe	2,000,000	0.0116	Services Rendered		Section 4(2)
4/12/2018	GHS Investments	4,000,000	0.0068	Note Payable Conversion		Rule 506
4/18/2018	GHS Investments	38,759,690	0.0103	Shares Sold		Rule 506
4/30/2018	Tom Blackington	121,655	0.0103	Services Rendered		Section 4(2)
5/3/2018	GHS Investments	24,089,250	0.0104	Shares Sold		Rule 506
5/22/2018	GHS Investments	18,373,196	0.0092	Shares Sold		Rule 506
5/31/2018	Tom Blackington	142,450	0.0088	Shares Sold		Rule 506
6/5/2018	GHS Investments	5,354,830	0.0061	Note Payable Conversion		Rule 506
6/21/2018	GHS Investments	27,846,535	0.0081	Shares Sold		Rule 506

3.1	Articles of Incorporation, as Amended⁽¹⁾

3.2	By-laws, as Amended⁽¹⁾

3.3	Certificate of Designation for Series A Preferred Stock⁽³⁾

3.4	Certificate of Amendment to Certificate of Designation for Series A Preferred Stock⁽⁶⁾

3.5	Second Certificate of Amendment to Certificate of Designation for Series A Preferred Stock⁽⁷⁾

5.1	Opinion of Laxague Law, Inc.⁽¹⁵⁾

10.1	Employment Agreement with Michael Welch⁽¹⁰⁾

10.2	Employment Agreement with Jens Mielke⁽¹⁰⁾

10.3	Employment Agreement with David M. Seeberger⁽¹⁰⁾

10.4	Employment Agreement with Charles Smith⁽¹⁰⁾

10.5	Employment Agreement with John Blackington⁽¹⁰⁾

10.6	Consulting Agreement with Gerry David⁽⁵⁾

10.7	Consulting Agreement with Kevin Harrington⁽⁵⁾

10.8	Consulting Agreement with Hal Kravitz⁽¹⁵⁾

10.9	Rocky Mountain High Brands, Inc. 2017 Incentive Plan⁽⁴⁾

10.10	Service Agreement for offices at 9101 LBJ Freeway, Suite 200, Dallas, TX⁽¹⁾

10.11	Distributorship Agreement with Vega Bros. Sales and Distribution, LLC⁽¹⁾

10.12	Water Purchase Agreement⁽²⁾

10.13	Operating and Management Agreement⁽²⁾

10.14	Membership Interest Purchase Agreement⁽²⁾

10.15	First Amended Operating and Management Agreement of Rocky Mountain High Water Company, LLC⁽⁸⁾


10.16	Indemnification and Release Agreement with Jerry Grisaffi⁽⁸⁾

10.17	LyonPride Music Sponsorship/Promo/Marketing Agreement with Rocky Mountain High Brands, Inc.⁽⁸⁾

10.18	LSW Holdings, LLC Convertible Promissory Note dated May 19, 2017⁽¹⁵⁾

10.19	LSW Holdings, LLC Convertible Promissory Note dated July 11, 2017⁽⁸⁾

10.20	Eagle Equities, LLC - Securities Purchase Agreement and Convertible Redeemable Notes Payable⁽⁸⁾

10.21	Equity Financing Agreement with GHS Investments, LLC⁽⁹⁾

10.22	Registration Rights Agreement with GHS Investments, LLC⁽⁹⁾

10.23	Secured Promissory Note with GHS Investments, LLC ($164,492.14 – Exchange for Note issued 10/12/17)⁽¹¹⁾

10.24	Secured Promissory Note with GHS Investments, LLC ($212,328,77 – Exchange for Note issued 11/2/17)⁽¹¹⁾

10.25	Secured Promissory Note with GHS Investments, LLC ($300,000 – Exchange for Note issued 1/5/18)⁽¹¹⁾

10.26	Secured Promissory Note with GHS Investments, LLC ($95,830 – Exchange for Note issued 1/11/18)⁽¹¹⁾

10.27	Securities Purchase Agreement with GHS Investments, LLC, dated June 27, 2018⁽¹¹⁾

10.28	Registration Rights Agreement with GHS Investments, LLC, dated June 27, 2018⁽¹¹⁾

10.29	Buy DMI, Inc. Fulfillment and Customer Support Services Agreement⁽¹²⁾

10.30	Secured Promissory Note and Exclusive Option Agreement with BFIT Brands, LLC⁽¹¹⁾

10.31	Agreement with KeHE Distributors, LLC⁽¹⁵⁾

10.32	Consulting Agreement with NutraGenecs⁽¹⁵⁾

10.33	Master Services Agreement with Tandem Theory, LLC⁽¹⁵⁾

10.34	Agreement with Buy DMi, Inc.⁽¹⁵⁾

10.35	Addendum to Agreement with Buy DMi, Inc.⁽¹⁵⁾

10.36	Consulting Agreement with Giovanni Gallucci⁽¹⁵⁾

10.37	Consulting Agreement with Tom Blackington⁽¹⁵⁾

10.38	Consulting Agreement with PKN Communications, Inc.⁽¹⁵⁾

10.39	Asset Purchase Agreement with BFIT Brands, LLC⁽¹⁶⁾

10.40	Non-competition Agreement with members of BFIT Brands, LLC⁽¹⁶⁾

10.41	Employment Agreement with Erik Rothchild⁽¹⁶⁾

10.42	Secured Promissory Note with GHS Investments, LLC ($157,500, issued 7/24/18)c⁽¹⁷⁾

10.43	Secured Promissory Note with GHS Investments, LLC ($157,500 issued 8/9/18)^*(18)

10.44	Secured Promissory Note with GHS Investments, LLC ($105,000 issued 8/30/18)*⁽¹⁸⁾

10.45	Addenda to Secured Promissory Notes*Notes⁽¹⁸⁾

10.46	Secured Promissory Note with GHS Investments, LLC ($131,250 issued 9/14/18)*

10.47	Secured Promissory Note with GHS Investments, LLC ($55,000 issued 9/28/18)*

14.1	Code of Conduct⁽¹⁰⁾

14.2	Insider Trading Policy⁽¹⁰⁾

21.1	List of Subsidiaries⁽¹⁵⁾

23.1	Consent of Independent Registered Public Accounting Firm*